<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JEB</journal-id>
<journal-id journal-id-type="hwp">spjeb</journal-id>
<journal-title>Journal of Educational and Behavioral Statistics</journal-title>
<issn pub-type="ppub">1076-9986</issn>
<issn pub-type="epub">1935-1054</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3102/1076998612461832</article-id>
<article-id pub-id-type="publisher-id">10.3102_1076998612461832</article-id>
<title-group>
<article-title>Covariate Adjustment Strategy Increases Power in the Randomized Controlled Trial With Discrete-Time Survival Endpoints</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Safarkhani</surname>
<given-names>Maryam</given-names>
</name>
<aff id="aff1-1076998612461832">Utrecht University</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moerbeek</surname>
<given-names>Mirjam</given-names>
</name>
<aff id="aff2-1076998612461832">Utrecht University</aff>
</contrib>
<bio>
<title>Authors</title>
<p>MARYAM SAFARKHANI is a PhD candidate at the department of Methodology and Statistics, Utrecht University, Box 80140, 3508 TC Utrecht, The Netherlands, e-mail: <email>m.safarkhani@uu.nl</email>. Her research interests focus on power and survival analyses, optimal design, as well as multilevel and latent variable analyses.</p>
<p>MIRJAM MOERBEEK, PhD, is an associate professor at the department of Methodology and Statistics, Utrecht University, POBox 80140, 3508 TC Utrecht, The Netherlands, e-mail: <email>m.moerbeek@uu.nl</email>, tel: +31-(0) 302531450. Her research interests include optimal design, structural equation modeling and multilevel modeling, power, and survival analyses.</p>
</bio>
</contrib-group>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>38</volume>
<issue>4</issue>
<fpage>355</fpage>
<lpage>380</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>12</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>25</day>
<month>4</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>7</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 AERA</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American Educational Research Association</copyright-holder>
</permissions>
<abstract>
<p>In a randomized controlled trial, a decision needs to be made about the total number of subjects for adequate statistical power. One way to increase the power of a trial is by including a predictive covariate in the model. In this article, the effects of various covariate adjustment strategies on increasing the power is studied for discrete-time survival endpoints; the circumstances are examined under which the covariate adjustment results in a sufficient increase in power. Using a predictive covariate may increase the costs for each subject, so it is useful to quantify when using a covariate is a cost-efficient strategy. The results reveal that using a covariate is highly recommended if the costs for measuring the covariate are relatively small and the correlation with the outcome sufficiently high.</p>
</abstract>
<kwd-group>
<kwd>randomized controlled trial</kwd>
<kwd>discrete-time survival endpoints</kwd>
<kwd>covariate adjustment strategy</kwd>
<kwd>simulation study</kwd>
<kwd>statistical power</kwd>
<kwd>cost-efficient strategy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1076998612461832">
<title>1. Introduction</title>
<p>The randomized controlled trial (RCT) is considered the most rigorous method for determining treatment effectiveness. Subjects in RCTs are randomly allocated to receive one of several treatments; the main aim is to compare one or more new treatments to a control. Various outcome variables can be considered for RCTs, such as continuous, binary, categorical (ordinal or nominal), counts, and survival endpoints. RCTs with survival endpoints that specify whether and, if so, when a specific event occurs, are encountered in social and behavioral as well as biomedical sciences. For example, <xref ref-type="bibr" rid="bibr17-1076998612461832">Masyn (2003)</xref> evaluates whether behavioral couples therapy would effectively decrease the risk of drinking and the domestic violence of alcohol-dependent males. All the subjects are randomized to one of three treatment groups and followed for 1 year. In each 2-month period, domestic violence is recorded if it occurs.</p>
<p>The timing of events is continuous if the target event occurs at any point in time. In this situation, time is measured using precise units as widely used in biomedical sciences, where the main event is often death. To deal with this type of survival data, continuous-time survival analyses can be performed; the most popular model is the Cox proportional hazard model (<xref ref-type="bibr" rid="bibr5-1076998612461832">Cox, 1972</xref>).</p>
<p>In social and behavioral sciences, however, the observed time might not be measured precisely and has to be recorded in discrete intervals for the following reasons: (1) Some events occur at a precise point in time but are only recorded at the end of each interval, as is common in prospective studies. Mental health professionals, for instance, might want to evaluate the effect of an inpatient alcohol treatment program on the risk of a drinking relapse among newly released patients. To examine the patients’ drinking status, it might be too expensive to contact them frequently. So investigators might consider discrete intervals for collecting the data, for example, years, months, or weeks. (2) Some events can only occur at discrete points in time. High school students for example can only graduate a few times a year, that is, at the end of each semester. (3) Data collection requirements may force researchers to consider intervals for recording time, especially in retrospective studies where subjects may not remember the exact time the event occurred. For example, it is difficult for adolescents to recall their exact age when they had their first suicidal thought.</p>
<p>To analyse this kind of data, discrete-time survival analysis is applied and the most common model is the discrete-time hazard model, as is well described by <xref ref-type="bibr" rid="bibr20-1076998612461832">Singer and Willett (1993</xref>, <xref ref-type="bibr" rid="bibr21-1076998612461832">2003</xref>). This model is a generalized linear model (GLM) and uses a combination of several logistic regression models, one for each time period. The model is of special interest because it can be easily used with standard software packages such as SPSS, SAS, R, and Mplus.</p>
<p>In recent decades, there has been growing interest in an experimental study with adequate statistical power, that is, to detect treatment effects with sufficient probability. As we know, the power depends on the sample size. If the sample size is extremely small, the effect of the treatment may not be detected at all, but including numerous subjects in a study might be a waste of time and money. The increasing interest in achieving a desired power has heightened the need for computational tools for calculating the required number of subjects before conducting trials. The power and sample size calculations have been extensively studied in continuous-time survival analyses. Many articles and books have been published in this field, for example, <xref ref-type="bibr" rid="bibr3-1076998612461832">Chow, Shao, and Wang (2008)</xref>, <xref ref-type="bibr" rid="bibr15-1076998612461832">Julious (2010)</xref>, <xref ref-type="bibr" rid="bibr4-1076998612461832">Collett (2003)</xref>, <xref ref-type="bibr" rid="bibr16-1076998612461832">Machin, Cheung, and Parmar (2006)</xref>, and <xref ref-type="bibr" rid="bibr12-1076998612461832">Hosmer, Lemeshow, and May (2008)</xref>. And many software packages perform these calculations, such as nQuery Advisor 7.0 (<xref ref-type="bibr" rid="bibr6-1076998612461832">Elashoff, 2005</xref>) and PASS (<xref ref-type="bibr" rid="bibr11-1076998612461832">Hintze, 2008</xref>). The relation between the power and the sample size has recently been investigated in studies with discrete-time endpoints. <xref ref-type="bibr" rid="bibr14-1076998612461832">Jóźwiak and Moerbeek (2012)</xref> derive the required number of subjects for sufficient power in an RCT with two equally sized treatment groups. This study has also been investigated for Cluster Randomized Trials by adding a random effect at the cluster level to the discrete-time hazard model, which is then called a generalized linear mixed model (<xref ref-type="bibr" rid="bibr18-1076998612461832">Moerbeek, in press</xref>).</p>
<p>Increasing the sample size not only increases the statistical power but also the costs of the study. Many researchers have recently opted to seek alternative methods for increasing the power without increasing the sample size. One way is by including a covariate and applying a multivariate analysis instead of a univariate one (<xref ref-type="bibr" rid="bibr1-1076998612461832">Allison, 1995</xref>). Recent studies have focused on this method of analyzing variance models (<xref ref-type="bibr" rid="bibr2-1076998612461832">Allison, Allison, Faith, Paultre, &amp; Pi-Sunyer, 1997</xref>), continuous-time survival analysis (<xref ref-type="bibr" rid="bibr9-1076998612461832">Hernandez, Eijkemans, &amp; Steyerberg, 2006</xref>), and on trials with dichotomous outcomes (see, for instance, <xref ref-type="bibr" rid="bibr10-1076998612461832">Hernandez, Steyerberg, &amp; Habbema, 2004</xref>; <xref ref-type="bibr" rid="bibr22-1076998612461832">Turner et al., 2012</xref>).</p>
<p>Not much has been done to evaluate the efficacy of including a predictive covariate in increasing the power of discrete-time survival analysis. This article assesses the extent to which the use of a predictive covariate can increase the power of an RCT with discrete-time survival endpoints. We focus on three covariate adjustment strategies: adjustment any time, adjustment only if the covariate has a significant effect on the outcome, and adjustment only if the covariate is imbalanced across treatment conditions. We also consider a survival function with a decreasing, constant and increasing hazard of event occurrence across time. Hernandez et al. (2006) investigate the effect of covariate adjustment strategies in RCTs with continuous-time survival endpoints, but only take a decreasing hazard function into account.</p>
<p>A principal reason to measure the additional covariate on each subject is to avoid rising trial costs. One might wonder whether it is useful to measure a covariate and reduce the sample size needed to achieve a desired power. <xref ref-type="bibr" rid="bibr1-1076998612461832">Allison (1995)</xref> derives a simple closed form expression, making it possible to determine when measuring a covariate is useful for achieving a powerful trial. So the second aim of this article is to properly address the problem of trials with discrete-time survival endpoints.</p>
<p>The remainder of this article is organized as follows. Section 2 is a brief introduction to the discrete-time hazard model. Section 3 describes the design factors and their corresponding levels in our simulation study, introduces the adjustment strategies, and shows which criteria are used to evaluate the strategies and compare their performances. Section 4 presents the results. Section 5 addresses the practical issue of the financial costs of covariate usage. We also illustrate the application of the adjustment strategies using two examples taken from social and behavioral research in Section 6. Conclusions and a discussion are given in Section 7.</p>
</sec>
<sec id="section2-1076998612461832">
<title>2. Discrete-Time Survival Analysis</title>
<p>Consider sample data from an RCT consisting of <italic>n</italic> independent subjects <italic>i</italic>, with <inline-formula id="inline-formula1-1076998612461832">
<mml:math id="mml-inline1-1076998612461832">
<mml:mi>i</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mo stretchy="false">…</mml:mo>
<mml:mo stretchy="false">,</mml:mo>
<mml:mi>n</mml:mi>
</mml:math>
</inline-formula> and five time intervals <inline-formula id="inline-formula2-1076998612461832">
<mml:math id="mml-inline2-1076998612461832">
<mml:mo stretchy="false">[</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> where <inline-formula id="inline-formula3-1076998612461832">
<mml:math id="mml-inline3-1076998612461832">
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mo stretchy="false">…</mml:mo>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mn>5</mml:mn>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula4-1076998612461832">
<mml:math id="mml-inline4-1076998612461832">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0</mml:mn>
</mml:math>
</inline-formula>, and <inline-formula id="inline-formula5-1076998612461832">
<mml:math id="mml-inline5-1076998612461832">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>5</mml:mn>
</mml:math>
</inline-formula>. We define a non-negative continuous random variable <inline-formula id="inline-formula6-1076998612461832">
<mml:math id="mml-inline6-1076998612461832">
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>, which measures the survival time for subject <inline-formula id="inline-formula7-1076998612461832">
<mml:math id="mml-inline7-1076998612461832">
<mml:mi>i</mml:mi>
</mml:math>
</inline-formula>, and a discrete random variable <inline-formula id="inline-formula8-1076998612461832">
<mml:math id="mml-inline8-1076998612461832">
<mml:msub>
<mml:mi mathvariant="normal">Γ</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>, which indicates the period during which the subject experiences the target event, that is, <inline-formula id="inline-formula9-1076998612461832">
<mml:math id="mml-inline9-1076998612461832">
<mml:msub>
<mml:mi mathvariant="normal">Γ</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>j</mml:mi>
</mml:math>
</inline-formula> if <inline-formula id="inline-formula10-1076998612461832">
<mml:math id="mml-inline10-1076998612461832">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">≤</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo stretchy="false">&lt;</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>. In this setting, the survival probability is defined as the probability that a subject has not yet experienced the event by the end of period <italic>j</italic>. In other words, it is the probability that he or she will experience the event after time <inline-formula id="inline-formula11-1076998612461832">
<mml:math id="mml-inline11-1076998612461832">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> and this is written as:<disp-formula id="disp-formula1-1076998612461832">
<mml:math id="mml-disp1-1076998612461832">
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">≥</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">Γ</mml:mi>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:munderover>
<mml:mo movablelimits="false" stretchy="false">∑</mml:mo>
<mml:mrow>
<mml:mi>k</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">+</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mn>5</mml:mn>
</mml:munderover>
</mml:mrow>
<mml:msub>
<mml:mi>P</mml:mi>
<mml:mi>f</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>k</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">,</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula1-1076998612461832" xlink:href="10.3102_1076998612461832-eq1.tif"/>
</disp-formula>
</p>
<p>where <inline-formula id="inline-formula12-1076998612461832">
<mml:math id="mml-inline12-1076998612461832">
<mml:msub>
<mml:mi>P</mml:mi>
<mml:mi>f</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>k</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> is an unknown probability mass function for <inline-formula id="inline-formula13-1076998612461832">
<mml:math id="mml-inline13-1076998612461832">
<mml:mi mathvariant="normal">Γ</mml:mi>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula14-1076998612461832">
<mml:math id="mml-inline14-1076998612461832">
<mml:msub>
<mml:mi>P</mml:mi>
<mml:mi>f</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">Γ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>.</p>
<p>The risk of event occurrence is defined by a discrete-time hazard probability, which is a conditional probability that a subject will experience the event in period <inline-formula id="inline-formula15-1076998612461832">
<mml:math id="mml-inline15-1076998612461832">
<mml:mi>j</mml:mi>
</mml:math>
</inline-formula>, given that the event has not occurred in an earlier period. This is expressed by:<disp-formula id="disp-formula2-1076998612461832">
<mml:math id="mml-disp2-1076998612461832">
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="normal">Γ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>j</mml:mi>
<mml:mrow>
<mml:mo>|</mml:mo>
</mml:mrow>
<mml:mi mathvariant="normal">Γ</mml:mi>
<mml:mo stretchy="false">≥</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi>P</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">≤</mml:mo>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">&lt;</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mrow>
<mml:mo>|</mml:mo>
</mml:mrow>
<mml:mi>T</mml:mi>
<mml:mo stretchy="false">≥</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula2-1076998612461832" xlink:href="10.3102_1076998612461832-eq2.tif"/>
</disp-formula>
</p>
<p>It can be concluded that the risk of event occurrence in period <inline-formula id="inline-formula16-1076998612461832">
<mml:math id="mml-inline16-1076998612461832">
<mml:mi>j</mml:mi>
</mml:math>
</inline-formula> depends on the survival probability then and in the previous period using the following formula:</p>
<p>
<disp-formula id="disp-formula3-1076998612461832">
<label>1</label>
<mml:math id="mml-disp3-1076998612461832">
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">]</mml:mo>
<mml:mrow>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula3-1076998612461832" xlink:href="10.3102_1076998612461832-eq3.tif"/>
</disp-formula>
</p>
<p>To assess the effect of predictors on the population discrete-time hazard function and compare the risk of event occurrence between various treatments, the population discrete-time hazard model is applied. It is a generalized linear model (GLM) and models the risk of event occurrence for subject <italic>i</italic> in period <inline-formula id="inline-formula17-1076998612461832">
<mml:math id="mml-inline17-1076998612461832">
<mml:mi>j</mml:mi>
</mml:math>
</inline-formula> as a function of the predictors. For five time periods and a logit link it is written as:</p>
<p>
<disp-formula id="disp-formula4-1076998612461832">
<mml:math id="mml-disp4-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">…</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mn>5</mml:mn>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo stretchy="false">+</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula4-1076998612461832" xlink:href="10.3102_1076998612461832-eq4.tif"/>
</disp-formula>
</p>
<p>Here <inline-formula id="inline-formula18-1076998612461832">
<mml:math id="mml-inline18-1076998612461832">
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:math>
</inline-formula> is a time indicator for the subject <italic>i</italic> and assumes the value 1 in period <italic>j</italic> and 0 in all the other periods. The variable <italic>Z</italic> indicates the treatment condition and is 0 for subjects in the control group and 1 for those in the experimental group. The variable <italic>C</italic> is a binary covariate assumed to denote gender in this article and subsequently scored as 0 for males and 1 for females. Both of the variables are time-invariant, which means the subjects cannot change their treatment condition or covariate value in the course of the study. The right-hand side of the formula is composed of two terms. In the first pair of brackets, the αs are multiplied by their corresponding time indicators and act as multiple intercepts, one for each period. Each intercept parameter α<italic>
<sub>j</sub>
</italic> represents the value of the logit hazard (log odds of event occurrence) in period <italic>j</italic> for the baseline group, which is a subset of the population where all the predictors are equal to zero. In the second pair of brackets, the βs are multiplied by their respective predictors and assess the effect of one unit increase in the value of the associated predictors on the logit of the probability of event occurrence in every period. The αs can represent the baseline logit hazard function and the βs the size of the vertical shift in this function corresponding to one unit difference in the predictors. The size of the gap is assumed to be identical across the periods. In other words, the model assumes that the effect of the predictors is constant over time, that is, the proportional odds assumption.</p>
<p>To fit discrete-time hazard models, data should be constructed in the form of a person-period data set. In this type of data, each subject has a separate record for each period provided he or she is still at risk of event occurrence in that period. Subject <italic>i</italic>, who experiences the event or drops out from the study for other reasons in period <italic>j</italic>, only has <inline-formula id="inline-formula19-1076998612461832">
<mml:math id="mml-inline19-1076998612461832">
<mml:msub>
<mml:mi>J</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> records in the data. Each record describes the subject’s values on <inline-formula id="inline-formula20-1076998612461832">
<mml:math id="mml-inline20-1076998612461832">
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:mo stretchy="false">⋯</mml:mo>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula21-1076998612461832">
<mml:math id="mml-inline21-1076998612461832">
<mml:mi>Z</mml:mi>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula22-1076998612461832">
<mml:math id="mml-inline22-1076998612461832">
<mml:mi>C</mml:mi>
</mml:math>
</inline-formula>, and the event indicator. This variable specifies whether the event occurs in the specific period and assumes the value 1 if the subject experiences the event.</p>
<p>The model parameters can be estimated based on full Maximum Likelihood (ML) techniques using the regular logistic regression machinery available in most general purpose statistical software packages. The Maximum Likelihood Estimates of parameters is obtained by maximizing the following ML equation:<disp-formula id="disp-formula5-1076998612461832">
<mml:math id="mml-disp5-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">L</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">k</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:munderover>
<mml:mo movablelimits="false" stretchy="false">∏</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>n</mml:mi>
</mml:munderover>
</mml:mrow>
<mml:mrow>
<mml:munderover>
<mml:mo movablelimits="false" stretchy="false">∏</mml:mo>
<mml:mrow>
<mml:mi>j</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>J</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
</mml:mrow>
</mml:munderover>
</mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mo stretchy="false">]</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mo stretchy="false">]</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo stretchy="false">,</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula5-1076998612461832" xlink:href="10.3102_1076998612461832-eq5.tif"/>
</disp-formula>
</p>
<p>where the variable <inline-formula id="inline-formula23-1076998612461832">
<mml:math id="mml-inline23-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
</mml:math>
</inline-formula> assumes the value 0 if subject <italic>i</italic> is not still experiencing the event up to and during period <italic>j</italic> and the value 1 if the subject experiences the event in period <italic>j</italic>.</p>
<sec id="section3-1076998612461832">
<title>2.1. Weibull Survival Function</title>
<p>We assume that the underlying time variable <italic>T</italic> is continuous. Different continuous functions can be used to describe its probability density function such as Exponential, Weibull, Lognormal, Gamma, or Gumbel. The Weibull distribution function is a common and flexible model for this purpose and we use it to model the survival for the baseline group. Without a loss of generality, time can be scaled between 0 and 1 with 0 as the beginning of the trial (<inline-formula id="inline-formula24-1076998612461832">
<mml:math id="mml-inline24-1076998612461832">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>) and 1 the end of the trial (<inline-formula id="inline-formula25-1076998612461832">
<mml:math id="mml-inline25-1076998612461832">
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>). Then the Weibull density function with shape parameter <inline-formula id="inline-formula26-1076998612461832">
<mml:math id="mml-inline26-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula> and scale parameter λ is as follows:<disp-formula id="disp-formula6-1076998612461832">
<mml:math id="mml-disp6-1076998612461832">
<mml:mi>f</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:msup>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo form="prefix" movablelimits="false">exp</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
<mml:msup>
<mml:mi>t</mml:mi>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:msup>
<mml:mo stretchy="false">)</mml:mo>
<mml:mtext> </mml:mtext>
<mml:mo stretchy="false">;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>0.</mml:mn>
</mml:math>
<graphic alternate-form-of="disp-formula6-1076998612461832" xlink:href="10.3102_1076998612461832-eq6.tif"/>
</disp-formula>
</p>
<p>The cumulative density function is given by <inline-formula id="inline-formula27-1076998612461832">
<mml:math id="mml-inline27-1076998612461832">
<mml:mi>F</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:msup>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:msup>
</mml:math>
</inline-formula>. According to this definition, the Weibull survival function for the baseline group is expressed as <inline-formula id="inline-formula28-1076998612461832">
<mml:math id="mml-inline28-1076998612461832">
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi mathvariant="italic">λ</mml:mi>
<mml:msup>
<mml:mi>t</mml:mi>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:msup>
</mml:mrow>
</mml:msup>
</mml:math>
</inline-formula> and the corresponding baseline hazard function is determined by <inline-formula id="inline-formula29-1076998612461832">
<mml:math id="mml-inline29-1076998612461832">
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi>t</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mi mathvariant="italic">λ</mml:mi>
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:msup>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:math>
</inline-formula>. The shape of the hazard function is characterized by the parameter <inline-formula id="inline-formula30-1076998612461832">
<mml:math id="mml-inline30-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">∈</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mi mathvariant="normal">∞</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>. The parameter λ can be replaced by <inline-formula id="inline-formula31-1076998612461832">
<mml:math id="mml-inline31-1076998612461832">
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>l</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> with <inline-formula id="inline-formula32-1076998612461832">
<mml:math id="mml-inline32-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">∈</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">]</mml:mo>
</mml:math>
</inline-formula> as the overall proportion of subjects in the baseline group who experience the event at some point in time during the study (<xref ref-type="bibr" rid="bibr7-1076998612461832">Galbraith &amp; Marschner, 2002</xref>). Then for any given value of ω, different patterns for the baseline survival and hazard function are defined, as are shown in <xref ref-type="fig" rid="fig1-1076998612461832">Figure 1</xref> for <inline-formula id="inline-formula33-1076998612461832">
<mml:math id="mml-inline33-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.8</mml:mn>
</mml:math>
</inline-formula> and three different values of τ. In this figure, the survival functions can be found in the upper half and the corresponding baseline hazard probabilities in the lower half. If <inline-formula id="inline-formula34-1076998612461832">
<mml:math id="mml-inline34-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>, the hazard probability is the highest at the beginning of the trial and decreases over time, which corresponds to trials where many subjects only experience the event after the study has been going on for a short time. We also observe that the survival function for this pattern drops rapidly during the periods with the highest risk of event occurrence and then declines slowly. For τ = 1, the hazard probability is constant across time, which implies that the corresponding survival function is almost linear over time periods, and for τ = 3, the hazard probability is the lowest at the beginning and increases over time and indicates trials with the highest risk concentrated toward the end. This pattern can be illustrated by the smaller reduction in the associated survival function at the beginning of the trial and the steeper reduction toward the end of the trial. For each survival pattern, five time periods are used. Using the survival probabilities <inline-formula id="inline-formula35-1076998612461832">
<mml:math id="mml-inline35-1076998612461832">
<mml:msub>
<mml:mi>S</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> at the end of period <italic>j</italic>, we are able to calculate the baseline discrete-time hazard probabilities at discrete interval <italic>j</italic> by considering the relation between <inline-formula id="inline-formula36-1076998612461832">
<mml:math id="mml-inline36-1076998612461832">
<mml:mi>h</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula37-1076998612461832">
<mml:math id="mml-inline37-1076998612461832">
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>t</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> as given in <xref ref-type="disp-formula" rid="disp-formula3-1076998612461832">Equation 1</xref>.</p>
<fig id="fig1-1076998612461832" position="float">
<label>Figure 1.</label>
<caption>
<p>Survival patterns and corresponding hazard probabilities in the baseline group for the simulation study (<inline-formula id="inline-formula38-1076998612461832">
<mml:math id="mml-inline38-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>).</p>
</caption>
<graphic xlink:href="10.3102_1076998612461832-fig1.tif"/>
</fig>
</sec>
</sec>
<sec id="section4-1076998612461832">
<title>3. Materials and Methods</title>
<p>This research focuses on RCTs with two groups, an experimental group, which is given a treatment, and a control group. The treatment is randomly assigned with equal probability to half the subjects. The impact of one binary covariate on increasing the power to detect the treatment effect is examined. Here, the covariate is gender; of course, any binary covariate can be used. Random allocation may result in a correlation between gender and treatment condition. In subsection 3.1, we first identify design factors and their corresponding levels, which are used in our simulation study. Then model and adjustment strategies are introduced and finally the criteria used for the evaluation of the strategies are given.</p>
<sec id="section5-1076998612461832">
<title>3.1. Design Factors and Simulation Study</title>
<p>In a simulation study, a small number of design factors are specified. This article covers six factors: covariate prevalence (<inline-formula id="inline-formula39-1076998612461832">
<mml:math id="mml-inline39-1076998612461832">
<mml:mi>p</mml:mi>
</mml:math>
</inline-formula>), that is, the proportion of subjects who are female, sample size (<italic>N</italic>), treatment effect (β<sub>1</sub>), covariate effect (β<sub>2</sub>), survival pattern (τ), and attrition rate (<italic>r</italic>). The attrition rate is defined as the proportion of subjects who leave the study between any two adjacent time points due to unforeseen reasons other than event occurrence. The factors and their levels are summarized in <xref ref-type="table" rid="table1-1076998612461832">Table 1</xref>.</p>
<table-wrap id="table1-1076998612461832" position="float">
<label>Table 1</label>
<caption>
<p>Overview of Factors and the Levels for the Simulation Study</p>
</caption>
<graphic alternate-form-of="table1-1076998612461832" xlink:href="10.3102_1076998612461832-table1.tif"/>
<table>
<thead>
<tr>
<th>Factor</th>
<th>Levels</th>
</tr>
</thead>
<tbody>
<tr>
<td>Covariate prevalence <italic>p</italic>
</td>
<td>0.1, 0.5</td>
</tr>
<tr>
<td>Sample size <italic>N</italic>
</td>
<td>200, 500, 1000</td>
</tr>
<tr>
<td>Treatment effect <inline-formula id="inline-formula40-1076998612461832">
<mml:math id="mml-inline40-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>1.0, 1.5, 1.7, 1.9</td>
</tr>
<tr>
<td>Covariate effect <inline-formula id="inline-formula41-1076998612461832">
<mml:math id="mml-inline41-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>
</td>
<td>1.5, 2.0, 4.0</td>
</tr>
<tr>
<td>Survival pattern for <inline-formula id="inline-formula42-1076998612461832">
<mml:math id="mml-inline42-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.8</mml:mn>
</mml:math>
</inline-formula>
</td>
<td>
</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula43-1076998612461832">
<mml:math id="mml-inline43-1076998612461832">
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>3</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>4</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> when <inline-formula id="inline-formula44-1076998612461832">
<mml:math id="mml-inline44-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</td>
<td>(0.45, −1.28, −1.68, −1.92, −2.10)</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula45-1076998612461832">
<mml:math id="mml-inline45-1076998612461832">
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>3</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>4</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> when <inline-formula id="inline-formula46-1076998612461832">
<mml:math id="mml-inline46-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</td>
<td>(−0.97, −0.97, −0.97, −0.97, −0.97)</td>
</tr>
<tr>
<td>
<inline-formula id="inline-formula47-1076998612461832">
<mml:math id="mml-inline47-1076998612461832">
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>3</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>4</mml:mn>
</mml:msub>
<mml:mo stretchy="false">,</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">α</mml:mi>
<mml:mn>5</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> when <inline-formula id="inline-formula48-1076998612461832">
<mml:math id="mml-inline48-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</td>
<td>(−4.35, −2.36, −1.28, −0.49, 0.18)</td>
</tr>
<tr>
<td>Attrition rate <italic>r</italic>
</td>
<td>0.00, 0.05, 0.10, 0.25</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1076998612461832">
<p>
<italic>Note:</italic> The survival rate <inline-formula id="inline-formula49-1076998612461832">
<mml:math id="mml-inline49-1076998612461832">
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula> is fixed at 0.2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The covariate prevalence and sample size are the same as in the study by <xref ref-type="bibr" rid="bibr9-1076998612461832">Hernandez et al. (2006)</xref>: <inline-formula id="inline-formula50-1076998612461832">
<mml:math id="mml-inline50-1076998612461832">
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>.1</mml:mn>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula51-1076998612461832">
<mml:math id="mml-inline51-1076998612461832">
<mml:mn>.5</mml:mn>
</mml:math>
</inline-formula> and <italic>N</italic> = 200, 500,  and 1,000. We use different covariate effects that can be expressed as small, mild, and large, that is, <inline-formula id="inline-formula52-1076998612461832">
<mml:math id="mml-inline52-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mn>2.0</mml:mn>
</mml:math>
</inline-formula>, and 4.0, respectively. Four values for the treatment effect are used: no, small, mild, and large effect, that is, <inline-formula id="inline-formula53-1076998612461832">
<mml:math id="mml-inline53-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
</mml:math>
</inline-formula>1, 1.5, 1.7, and 1.9, respectively. Three logit hazard functions for the baseline group are defined with three survival patterns using different values for the Weibull shape parameter (τ), see <xref ref-type="fig" rid="fig1-1076998612461832">Figure 1</xref>. For this figure, the overall surviving proportion at the end of the study for the baseline group is assumed to be 0.2 (<inline-formula id="inline-formula54-1076998612461832">
<mml:math id="mml-inline54-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.8</mml:mn>
</mml:math>
</inline-formula>). Attrition is assumed to be constant across time and four levels for attrition rate are defined: <inline-formula id="inline-formula55-1076998612461832">
<mml:math id="mml-inline55-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mn>0.05</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mn>0.10</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula56-1076998612461832">
<mml:math id="mml-inline56-1076998612461832">
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>.</p>
<p>There are 864 possible combinations of all the design factor levels called simulation conditions. Using the program R, 10,000 data sets are generated in each simulation condition if there is a treatment effect (<italic>OR</italic>(β<sub>1</sub>) &gt; 1) and 100,000 data sets if there is not (<italic>OR</italic>(β<sub>1</sub>) = 1). For a few simulation combinations, more data sets are simulated, but the results are observed to become stable after 10,000 or 100,000 replications.</p>
</sec>
<sec id="section6-1076998612461832">
<title>3.2. Model and Adjustment Strategies</title>
<p>For each simulated data set, the discrete-time hazard model is used to estimate the effect of the treatment condition on the probability of event occurrence. There are three adjustment strategies to evaluate the effect of the covariate on increasing the treatment effect detection power. The first strategy adjusts the treatment effect using a predefined covariate; it always includes the covariate in the model and is called the prespecified strategy. In the second strategy, the covariate is considered for adjustment if it has a significant effect on the outcome in a model without the treatment condition as a predictor variable (using the Wald test statistic and <italic>p</italic> &lt; .05); it is called the significant-predictor strategy. The third strategy defines another constraint for adjustment; it only includes a covariate in the model if it is significantly correlated with the treatment (imbalance allocation) and is called the significant-imbalance strategy. The imbalance allocation is assessed on the basis of the Pearson chi-square test with 1 <italic>df</italic> (<italic>p</italic> &lt; .05).</p>
</sec>
<sec id="section7-1076998612461832">
<title>3.3. Criteria for Evaluation</title>
<p>To evaluate the effect of the adjustment strategies on the estimate of the treatment effect (β<sub>1</sub>) and its standard error, we focus on the relative parameter bias and the relative standard error bias of this parameter. The relative parameter bias is given by:<disp-formula id="disp-formula7-1076998612461832">
<mml:math id="mml-disp7-1076998612461832">
<mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">p</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">b</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mover>
<mml:msub>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo accent="false" stretchy="true">‾</mml:mo>
</mml:mover>
<mml:mo stretchy="false">−</mml:mo>
<mml:msub>
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">,</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula7-1076998612461832" xlink:href="10.3102_1076998612461832-eq7.tif"/>
</disp-formula>
</p>
<p>if β<sub>1</sub> is the true parameter value for the treatment effect and <inline-formula id="inline-formula57-1076998612461832">
<mml:math id="mml-inline57-1076998612461832">
<mml:mover>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo accent="false" stretchy="true">‾</mml:mo>
</mml:mover>
</mml:math>
</inline-formula> is its estimate, which is averaged over all the simulated data sets, that is, <inline-formula id="inline-formula58-1076998612461832">
<mml:math id="mml-inline58-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mrow>
<mml:msubsup>
<mml:mo movablelimits="false" stretchy="false">∑</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
<mml:mi>b</mml:mi>
</mml:msubsup>
</mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mi>i</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mi>b</mml:mi>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> if <italic>b</italic> is the number of replications. The relative standard error bias is calculated in the same way as the relative parameter bias, which subtracts the standard deviation of <italic>b</italic> treatment effect estimates <inline-formula id="inline-formula59-1076998612461832">
<mml:math id="mml-inline59-1076998612461832">
<mml:mi>S</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" mathvariant="normal" stretchy="false">ˆ</mml:mo>
</mml:mover>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> from the average of the estimated standard errors over all replications <inline-formula id="inline-formula60-1076998612461832">
<mml:math id="mml-inline60-1076998612461832">
<mml:mover>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" mathvariant="normal" stretchy="false">ˆ</mml:mo>
</mml:mover>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo accent="false" stretchy="true">‾</mml:mo>
</mml:mover>
</mml:math>
</inline-formula> and divides it by the first term. In other words, it is defined by:<disp-formula id="disp-formula8-1076998612461832">
<mml:math id="mml-disp8-1076998612461832">
<mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
<mml:mi mathvariant="normal">e</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">s</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">n</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">d</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">e</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">r</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">b</mml:mi>
<mml:mi mathvariant="normal">i</mml:mi>
<mml:mi mathvariant="normal">a</mml:mi>
<mml:mi mathvariant="normal">s</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mover>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" mathvariant="normal" stretchy="false">ˆ</mml:mo>
</mml:mover>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mo accent="false" stretchy="true">‾</mml:mo>
</mml:mover>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>S</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mi>D</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula8-1076998612461832" xlink:href="10.3102_1076998612461832-eq8.tif"/>
</disp-formula>
</p>
<p>
<xref ref-type="bibr" rid="bibr19-1076998612461832">Muthén and Muthén (2002)</xref> suggest that the absolute values of parameter bias and standard error bias should not exceed 10% and 5%, respectively.</p>
<p>The power (probability of rejecting the null hypothesis if it is false) of the treatment effect is estimated using the proportion of the simulated data sets for which the null hypothesis of no treatment effect is rejected in a two-sided test with a default significance level of 5%. This proportion is an estimate of Type I error rate (probability of rejecting the null hypothesis if it is true) for the treatment effect with a population value equal to zero. The Wald statistic is used to evaluate the statistical significance of the treatment and calculated by dividing the treatment effect estimate by its standard error (<inline-formula id="inline-formula61-1076998612461832">
<mml:math id="mml-inline61-1076998612461832">
<mml:mi>W</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:mover accent="true">
<mml:mi>S</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mi>E</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mover accent="true">
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mo accent="true" stretchy="false">ˆ</mml:mo>
</mml:mover>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>) and referring to the 97.5th quantile of the standard normal distribution.</p>
<p>To identify whether and which adjustment strategies increase the statistical power for β<sub>1</sub>, we consider the Reduction in sample size (RSS), which is defined as the decrease in the required sample size of an adjustment strategy that gives the same power as an unadjusted model. Following <xref ref-type="bibr" rid="bibr10-1076998612461832">Hernandez et al. (2004)</xref>, the RSS can be expressed in a percentage by: <disp-formula id="disp-formula9-1076998612461832">
<mml:math id="mml-disp9-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo stretchy="false">×</mml:mo>
<mml:msup>
<mml:mfenced close=")" open="(">
<mml:mrow>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo stretchy="false">,</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula9-1076998612461832" xlink:href="10.3102_1076998612461832-eq9.tif"/>
</disp-formula>
</p>
<p>if <inline-formula id="inline-formula62-1076998612461832">
<mml:math id="mml-inline62-1076998612461832">
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> is the average of the standardized <italic>Z</italic> scores over all the simulated data sets for the unadjusted strategy and <inline-formula id="inline-formula63-1076998612461832">
<mml:math id="mml-inline63-1076998612461832">
<mml:msub>
<mml:mi>Z</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> is the corresponding mean standardized <italic>Z</italic> score of the adjusted strategy.</p>
</sec>
</sec>
<sec id="section8-1076998612461832">
<title>4. Results</title>
<p>We first discuss the simulation results for a specific combination of design factors, which yields the lowest power provided there is no attrition. In other words, we first study the case where subjects only leave the study if they experience the event of interest. This combination is defined using a sample size of 200 and a covariate prevalence of 50<inline-formula id="inline-formula64-1076998612461832">
<mml:math id="mml-inline64-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>. In addition, the hazard function for the baseline group decreases over time (<inline-formula id="inline-formula65-1076998612461832">
<mml:math id="mml-inline65-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>). The percentage of rejection and the RSS for all the treatment and covariate effects are presented in <xref ref-type="table" rid="table2-1076998612461832">Table 2</xref>. The reported values of the rejection column are either the Type I error rate if there is no treatment effect (<inline-formula id="inline-formula66-1076998612461832">
<mml:math id="mml-inline66-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>) or the power of the treatment effect (<inline-formula id="inline-formula67-1076998612461832">
<mml:math id="mml-inline67-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>). Since none of the parameter and standard error biases of the treatment effect exceed their critical values of 10% and 5% in absolute value, they are not given in the table.</p>
<table-wrap id="table2-1076998612461832" position="float">
<label>Table 2</label>
<caption>
<p>Simulation Results With Covariate Prevalence 50%, <inline-formula id="inline-formula68-1076998612461832">
<mml:math id="mml-inline68-1076998612461832">
<mml:mrow>
<mml:mi mathvariant="normal">N</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>200</mml:mn>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula69-1076998612461832">
<mml:math id="mml-inline69-1076998612461832">
<mml:mrow>
<mml:mo>τ</mml:mo>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn mathvariant="italic">1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn mathvariant="italic">3</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> , No Attrition, and <inline-formula id="inline-formula70-1076998612461832">
<mml:math id="mml-inline70-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mo>ω</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>
</p>
</caption>
<graphic alternate-form-of="table2-1076998612461832" xlink:href="10.3102_1076998612461832-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="6">Covariate Effect</th>
</tr>
<tr>
<th rowspan="3">Treatment Effect and Adjustment Strategy</th>
<th colspan="2">Small (<inline-formula id="inline-formula71-1076998612461832">
<mml:math id="mml-inline71-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>)</th>
<th colspan="2">Mild (<inline-formula id="inline-formula72-1076998612461832">
<mml:math id="mml-inline72-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>2</mml:mn>
</mml:math>
</inline-formula>)</th>
<th colspan="2">Large (<inline-formula id="inline-formula73-1076998612461832">
<mml:math id="mml-inline73-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>4</mml:mn>
</mml:math>
</inline-formula>)</th>
</tr>
<tr>
<th>Rejection</th>
<th>RSS</th>
<th>Rejection</th>
<th>RSS</th>
<th>Rejection</th>
<th>RSS</th>
</tr>
<tr>
<th>(%)</th>
<th>(%)</th>
<th>(%)</th>
<th>(%)</th>
<th>(%)</th>
<th>(%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>No (<inline-formula id="inline-formula74-1076998612461832">
<mml:math id="mml-inline74-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.0</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>5.1</td>
<td>
</td>
<td>5.2</td>
<td>
</td>
<td>5.3</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>5.2</td>
<td>
</td>
<td>5.3</td>
<td>
</td>
<td>5.3</td>
<td>
</td>
</tr>
<tr>
<td> Sig-predictor</td>
<td>5.2</td>
<td>
</td>
<td>5.3</td>
<td>
</td>
<td>5.3</td>
<td>
</td>
</tr>
<tr>
<td> Sig-Imbalance</td>
<td>5.1</td>
<td>
</td>
<td>5.1</td>
<td>
</td>
<td>4.9</td>
<td>
</td>
</tr>
<tr>
<td>Small (<inline-formula id="inline-formula75-1076998612461832">
<mml:math id="mml-inline75-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>38.9</td>
<td>
</td>
<td>34.9</td>
<td>
</td>
<td>27.8</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>
<bold>39.5</bold>
</td>
<td>
<bold>1.86</bold>
</td>
<td>
<bold>36.4</bold>
</td>
<td>
<bold>4.86</bold>
</td>
<td>
<bold>31.6</bold>
</td>
<td>
<bold>13.05</bold>
</td>
</tr>
<tr>
<td> Sig-predictor</td>
<td>39.1</td>
<td>0.45</td>
<td>36.0</td>
<td>3.70</td>
<td>31.6</td>
<td>13.05</td>
</tr>
<tr>
<td> Sig-Imbalance</td>
<td>38.8</td>
<td>0.07</td>
<td>34.9</td>
<td>0.22</td>
<td>27.9</td>
<td>0.94</td>
</tr>
<tr>
<td>Mild (<inline-formula id="inline-formula76-1076998612461832">
<mml:math id="mml-inline76-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.7</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>57.5</td>
<td>
</td>
<td>53.1</td>
<td>
</td>
<td>41.6</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>
<bold>58.3</bold>
</td>
<td>
<bold>1.82</bold>
</td>
<td>
<bold>54.8</bold>
</td>
<td>
<bold>5.31</bold>
</td>
<td>
<bold>46.7</bold>
</td>
<td>
<bold>13.04</bold>
</td>
</tr>
<tr>
<td> Sig-predictor</td>
<td>57.6</td>
<td>0.51</td>
<td>54.3</td>
<td>4.26</td>
<td>46.7</td>
<td>13.02</td>
</tr>
<tr>
<td> Sig-Imbalance</td>
<td>57.5</td>
<td>0.01</td>
<td>53.3</td>
<td>0.36</td>
<td>42.1</td>
<td>1.28</td>
</tr>
<tr>
<td>Large (<inline-formula id="inline-formula77-1076998612461832">
<mml:math id="mml-inline77-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.9</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>72.6</td>
<td>
</td>
<td>67.5</td>
<td>
</td>
<td>56.1</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>
<bold>73.5</bold>
</td>
<td>
<bold>1.75</bold>
</td>
<td>
<bold>69.8</bold>
</td>
<td>
<bold>4.76</bold>
</td>
<td>
<bold>61.8</bold>
</td>
<td>
<bold>12.22</bold>
</td>
</tr>
<tr>
<td> Sig-predictor</td>
<td>72.9</td>
<td>0.50</td>
<td>69.1</td>
<td>3.64</td>
<td>61.8</td>
<td>12.18</td>
</tr>
<tr>
<td> Sig-Imbalance</td>
<td>72.6</td>
<td>0.00</td>
<td>67.7</td>
<td>0.43</td>
<td>56.4</td>
<td>0.81</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1076998612461832">
<p>
<italic>Note:</italic> Rejection is either the Type I error rate when <inline-formula id="inline-formula78-1076998612461832">
<mml:math id="mml-inline78-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> or the power for <inline-formula id="inline-formula79-1076998612461832">
<mml:math id="mml-inline79-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>. For each combination of <inline-formula id="inline-formula80-1076998612461832">
<mml:math id="mml-inline80-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula81-1076998612461832">
<mml:math id="mml-inline81-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, the results of the best adjustment strategy are presented in boldface.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>
<xref ref-type="table" rid="table2-1076998612461832">Table 2</xref> shows that since a covariate with a large effect is nearly always a predictive covariate, the prespecified and significant-predictor strategies primarily generate similar results for a large covariate effect. Furthermore, if either the unadjusted strategy or the significant-imbalance strategy are used, there are no considerable differences between the results. For a sample size equal to 200, there is hardly ever a significant imbalance allocation during a randomization sequence. For instance, for all the simulation conditions with <inline-formula id="inline-formula82-1076998612461832">
<mml:math id="mml-inline82-1076998612461832">
<mml:mi>N</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>200</mml:mn>
</mml:math>
</inline-formula>, an imbalanced allocation solely occurs in less than 7% of the data sets. So the results with the unadjusted and significant-imbalance strategies are almost similar.</p>
<p>To assess the strategies in greater detail, we first consider the results for a trial with no treatment effect (<inline-formula id="inline-formula83-1076998612461832">
<mml:math id="mml-inline83-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>). The Type I error rates are almost similar in all the strategies and they are close to their nominal level of 5% within each covariate effect. We then focus on the results obtained if the treatment is not absent (<inline-formula id="inline-formula84-1076998612461832">
<mml:math id="mml-inline84-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>). With the prespecified strategy, the power is greater than with the unadjusted strategy within each treatment and covariate effect. The difference in power between these two strategies is somewhat higher for a larger covariate effect. Conversely, power with the significant-predictor strategy only slightly increases as compared to the unadjusted one when the covariate effect is small. As the covariate effect grows, so does the increase in power. It is evident that the difference between the prespecified and the significant-predictor strategies in estimating the treatment effect is directly related to the strength of the covariate effect. In other words, the larger the covariate effect, the smaller the difference. The power compared with no adjustment does not change at all or only negligibly when the significant-imbalance strategy is used. This strategy also results in a minor decrease in the power of the simulation condition with small treatment and covariate effects. A potential reduction in sample size is observed with a large covariate effect when the prespecified and significant-predictor strategies are used. For a smaller covariate effect, the prespecified strategy yields much smaller reductions and the significant-predictor strategy only slightly reduces the sample size. Since the significant-imbalance strategy mainly yields similar results to the unadjusted analysis, it generally results in minor or negligible reductions.</p>
<p>As is obvious, given a certain covariate effect, a considerably larger power is observed for a larger treatment effect, but the RSS only slightly changes with different treatment effects. It should also be noted that for a given treatment effect, increasing the covariate effect results in a lower power but a higher RSS. Since these relations are also observed in all the tables below, we do not point them out in the following subsections.</p>
<p>We shall discuss below how the results change if we change the level of the covariate prevalence, sample size, survival pattern, and attrition rate. We only consider the unadjusted and prespecified strategies. Although a slight difference between the prespecified and significant-predictor strategies is observed when the covariate effect is small, in general these two strategies yield similar results. Since the significant-imbalance strategy is also observed to mainly behave in much the same way as the unadjusted strategy, the significant-predictor and significant-imbalance strategies are not denoted in any of the tables below.</p>
<sec id="section9-1076998612461832">
<title>4.1. The Effect of Covariate Prevalence</title>
<p>The results in <xref ref-type="table" rid="table2-1076998612461832">Table 2</xref> are for trials with a covariate prevalence equal to 50%. <xref ref-type="table" rid="table3-1076998612461832">Table 3</xref> shows a summary of the results for covariate prevalences of 50% and 10%. It should be noted that with <inline-formula id="inline-formula85-1076998612461832">
<mml:math id="mml-inline85-1076998612461832">
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>.1</mml:mn>
</mml:math>
</inline-formula>, for all the simulation conditions the parameter and standard error biases are never larger than 5% in absolute value. So a smaller covariate prevalence results in smaller parameter biases.</p>
<table-wrap id="table3-1076998612461832" position="float">
<label>Table 3</label>
<caption>
<p>Simulation Results as a Function of Covariate Prevalence (<inline-formula id="inline-formula86-1076998612461832">
<mml:math id="mml-inline86-1076998612461832">
<mml:mrow>
<mml:mi mathvariant="normal">N</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">200</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula87-1076998612461832">
<mml:math id="mml-inline87-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn mathvariant="italic">1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn mathvariant="italic">3</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>, No Attrition, and <inline-formula id="inline-formula88-1076998612461832">
<mml:math id="mml-inline88-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>)</p>
</caption>
<graphic alternate-form-of="table3-1076998612461832" xlink:href="10.3102_1076998612461832-table3.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th colspan="17">Covariate Effect</th>
<td>
</td>
</tr>
<tr>
<th>
</th>
<th colspan="6">Small (<inline-formula id="inline-formula89-1076998612461832">
<mml:math id="mml-inline89-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Mild (<inline-formula id="inline-formula90-1076998612461832">
<mml:math id="mml-inline90-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>2</mml:mn>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Large (<inline-formula id="inline-formula91-1076998612461832">
<mml:math id="mml-inline91-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>4</mml:mn>
</mml:math>
</inline-formula>)</th>
</tr>
<tr>
<th>Treatment Effect and Adjustment Strategies</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
</tr>
<tr>
<th>
</th>
<th>
<italic>p</italic> = .5</th>
<th>
<italic>p</italic> = .01</th>
<th colspan="2">
<italic>p</italic> = .5</th>
<th>
<italic>p</italic> = .01</th>
<th colspan="2">
<italic>p</italic> = .5</th>
<th>
<italic>p</italic> = .01</th>
<th colspan="2">
<italic>p</italic> = .5</th>
<th>
<italic>p</italic> = .01</th>
<th colspan="2">
<italic>p</italic> = .5</th>
<th>
<italic>p</italic> = .01</th>
<th colspan="2">
<italic>p</italic> = .5</th>
<th>
<italic>p</italic> = .01</th>
</tr>
</thead>
<tbody>
<tr>
<td>No (<inline-formula id="inline-formula92-1076998612461832">
<mml:math id="mml-inline92-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>5.1</td>
<td>5.2</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">5.2</td>
<td>5.1</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">5.3</td>
<td>5.2</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>5.2</td>
<td>5.3</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">5.3</td>
<td>5.1</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">5.3</td>
<td>5.2</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Small (<inline-formula id="inline-formula93-1076998612461832">
<mml:math id="mml-inline93-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>39</td>
<td>40</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">35</td>
<td>41</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">28</td>
<td>38</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>39</td>
<td>
<bold>40</bold>
</td>
<td colspan="2">
<bold>1.9</bold>
</td>
<td>0.4</td>
<td colspan="2">36</td>
<td>
<bold>42</bold>
</td>
<td colspan="2">
<bold>4.9</bold>
</td>
<td>1.2</td>
<td colspan="2">32</td>
<td>
<bold>40</bold>
</td>
<td colspan="2">
<bold>13.1</bold>
</td>
<td>2.7</td>
<td>
</td>
</tr>
<tr>
<td>Mild (<inline-formula id="inline-formula94-1076998612461832">
<mml:math id="mml-inline94-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.7</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>58</td>
<td>62</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">53</td>
<td>60</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">42</td>
<td>58</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>58</td>
<td>
<bold>62</bold>
</td>
<td colspan="2">
<bold>1.8</bold>
</td>
<td>0.3</td>
<td colspan="2">55</td>
<td>
<bold>61</bold>
</td>
<td colspan="2">
<bold>5.3</bold>
</td>
<td>1.3</td>
<td colspan="2">47</td>
<td>
<bold>59</bold>
</td>
<td colspan="2">
<bold>13.0</bold>
</td>
<td>2.5</td>
<td>
</td>
</tr>
<tr>
<td>Large (<inline-formula id="inline-formula95-1076998612461832">
<mml:math id="mml-inline95-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.9</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>73</td>
<td>77</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">68</td>
<td>75</td>
<td colspan="2">
</td>
<td>
</td>
<td colspan="2">56</td>
<td>74</td>
<td colspan="2">
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>74</td>
<td>
<bold>77</bold>
</td>
<td colspan="2">
<bold>1.7</bold>
</td>
<td>0.4</td>
<td colspan="2">70</td>
<td>
<bold>76</bold>
</td>
<td colspan="2">
<bold>4.8</bold>
</td>
<td>1.0</td>
<td colspan="2">62</td>
<td>
<bold>75</bold>
</td>
<td colspan="2">
<bold>12.2</bold>
</td>
<td>2.4</td>
<td>
</td>
</tr>
<tr>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1076998612461832">
<p>
<italic>Note:</italic> Rejection is either the Type I error rate when <inline-formula id="inline-formula96-1076998612461832">
<mml:math id="mml-inline96-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> or the power for <inline-formula id="inline-formula97-1076998612461832">
<mml:math id="mml-inline97-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>. For each combination of <inline-formula id="inline-formula98-1076998612461832">
<mml:math id="mml-inline98-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula99-1076998612461832">
<mml:math id="mml-inline99-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, the covariate prevalence with the highest reduction in sample size and power is presented in boldface.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Using different covariate prevalences, inconsiderable differences in the Type I error rates are found and they are all close to their nominal values. If <inline-formula id="inline-formula100-1076998612461832">
<mml:math id="mml-inline100-1076998612461832">
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>.1</mml:mn>
</mml:math>
</inline-formula>, the power estimate with the prespecified strategy is similar to or slightly higher than on the basis of the unadjusted strategy, particularly if the covariate effect is small, though for a larger covariate effect, the adjusted power has somewhat larger values than the unadjusted one for <inline-formula id="inline-formula101-1076998612461832">
<mml:math id="mml-inline101-1076998612461832">
<mml:mi>p</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>.5</mml:mn>
</mml:math>
</inline-formula>. As a result, only modest values for the RSS are observed if one uses a much smaller covariate prevalence of 10%.</p>
<p>With a smaller covariate prevalence, the power is higher and the RSS is smaller than in the case of a larger prevalence.</p>
</sec>
<sec id="section10-1076998612461832">
<title>4.2. The Effect of the Sample Size</title>
<p>To study the effect of the sample size on the strategies, we examine the results for various sample sizes and present them in <xref ref-type="table" rid="table4-1076998612461832">Table 4</xref>. Using different sample sizes does not affect the Type I error rates and they differ slightly from their nominal level of 5%. The power of any treatment and covariate effect increases if the sample size increases. There is no clear relation between the RSS and the sample size. In other words, the results indicate a similar RSS with different sample sizes.</p>
<table-wrap id="table4-1076998612461832" position="float">
<label>Table 4</label>
<caption>
<p>Simulation Results as a Function of Sample Size (Covariate Prevalence 50%, <inline-formula id="inline-formula102-1076998612461832">
<mml:math id="mml-inline102-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mo>τ</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn mathvariant="italic">1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn mathvariant="italic">3</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>, No Attrition, and <inline-formula id="inline-formula103-1076998612461832">
<mml:math id="mml-inline103-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mo>ω</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>)</p>
</caption>
<graphic alternate-form-of="table4-1076998612461832" xlink:href="10.3102_1076998612461832-table4.tif"/>
<table>
<thead>
<tr>
<th rowspan="4">Treatment Effect and Adjustment Strategies</th>
<th colspan="18">Covariate Effect</th>
</tr>
<tr>
<th colspan="6">Small (<inline-formula id="inline-formula104-1076998612461832">
<mml:math id="mml-inline104-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">1</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">.5</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Mild (<inline-formula id="inline-formula105-1076998612461832">
<mml:math id="mml-inline105-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Large (<inline-formula id="inline-formula106-1076998612461832">
<mml:math id="mml-inline106-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">4</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
</tr>
<tr>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
</tr>
<tr>
<th>
<italic>N</italic> = 200</th>
<th>
<italic>N</italic> = 500</th>
<th>
<italic>N</italic> = 1000</th>
<th>
<italic>N</italic> = 200</th>
<th>
<italic>N</italic> = 500</th>
<th>
<italic>N</italic> = 1000</th>
<th>
<italic>N</italic> = 200</th>
<th>
<italic>N</italic> = 500</th>
<th>
<italic>N</italic> = 1000</th>
<th>
<italic>N</italic> = 200</th>
<th>
<italic>N</italic> = 500</th>
<th>
<italic>N</italic> = 1000</th>
<th>
<italic>N</italic> = 200</th>
<th>
<italic>N</italic> = 500</th>
<th>
<italic>N</italic> = 1000</th>
<th>
<italic>N</italic> = 200</th>
<th>
<italic>N</italic> = 500</th>
<th>
<italic>N</italic> = 1000</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="19">No (<inline-formula id="inline-formula107-1076998612461832">
<mml:math id="mml-inline107-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>) </td>
</tr>
<tr>
<td> Unadjusted </td>
<td>5.1</td>
<td>5.0</td>
<td>4.9</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.2</td>
<td>5.1</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.0</td>
<td>5.0</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified </td>
<td>5.2</td>
<td>5.0</td>
<td>4.9</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.2</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.0</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td colspan="19">Small (<inline-formula id="inline-formula108-1076998612461832">
<mml:math id="mml-inline108-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>) </td>
</tr>
<tr>
<td> Unadjusted </td>
<td>39</td>
<td>75</td>
<td>96</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>35</td>
<td>69</td>
<td>94</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>28</td>
<td>58</td>
<td>85</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified </td>
<td>39</td>
<td>76</td>
<td>
<bold>96</bold>
</td>
<td>1.9</td>
<td>1.9</td>
<td>
<bold>2.0</bold>
</td>
<td>36</td>
<td>72</td>
<td>
<bold>96</bold>
</td>
<td>4.9</td>
<td>
<bold>5.2</bold>
</td>
<td>5.1</td>
<td>32</td>
<td>64</td>
<td>
<bold>90</bold>
</td>
<td>13.1</td>
<td>14.3</td>
<td>
<bold>14.3</bold>
</td>
</tr>
<tr>
<td colspan="19">Mild (<inline-formula id="inline-formula109-1076998612461832">
<mml:math id="mml-inline109-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.7</mml:mn>
</mml:math>
</inline-formula>) </td>
</tr>
<tr>
<td> Unadjusted </td>
<td>58</td>
<td>93</td>
<td>100</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>53</td>
<td>90</td>
<td>100</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>42</td>
<td>80</td>
<td>98</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified </td>
<td>58</td>
<td>93</td>
<td>
<bold>100</bold>
</td>
<td>1.8</td>
<td>
<bold>1.9</bold>
</td>
<td>1.8</td>
<td>55</td>
<td>91</td>
<td>
<bold>100</bold>
</td>
<td>
<bold>5.3</bold>
</td>
<td>5.1</td>
<td>5.1</td>
<td>47</td>
<td>85</td>
<td>
<bold>99</bold>
</td>
<td>13.0</td>
<td>12.9</td>
<td>
<bold>13.4</bold>
</td>
</tr>
<tr>
<td colspan="19">Large (<inline-formula id="inline-formula110-1076998612461832">
<mml:math id="mml-inline110-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.9</mml:mn>
</mml:math>
</inline-formula>) </td>
</tr>
<tr>
<td> Unadjusted </td>
<td>73</td>
<td>98</td>
<td>100</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>68</td>
<td>97</td>
<td>100</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>56</td>
<td>91</td>
<td>100</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified </td>
<td>74</td>
<td>98</td>
<td>
<bold>100</bold>
</td>
<td>1.7</td>
<td>1.8</td>
<td>
<bold>1.8</bold>
</td>
<td>70</td>
<td>98</td>
<td>
<bold>100</bold>
</td>
<td>
<bold>4.8</bold>
</td>
<td>4.7</td>
<td>4.7</td>
<td>62</td>
<td>95</td>
<td>
<bold>100</bold>
</td>
<td>12.2</td>
<td>12.2</td>
<td>
<bold>12.6</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1076998612461832">
<p>
<italic>Note:</italic> Rejection is either the Type I error rate when <inline-formula id="inline-formula111-1076998612461832">
<mml:math id="mml-inline111-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> or the power for <inline-formula id="inline-formula112-1076998612461832">
<mml:math id="mml-inline112-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>. For each combination of <inline-formula id="inline-formula113-1076998612461832">
<mml:math id="mml-inline113-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula114-1076998612461832">
<mml:math id="mml-inline114-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, the sample size with the highest reduction in sample size and power is presented in boldface.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section11-1076998612461832">
<title>4.3. The Effect of the Survival Pattern</title>
<p>To address the performance of the strategies under various hazard probability functions, the results based on three different survival patterns (<inline-formula id="inline-formula115-1076998612461832">
<mml:math id="mml-inline115-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula116-1076998612461832">
<mml:math id="mml-inline116-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>, and <inline-formula id="inline-formula117-1076998612461832">
<mml:math id="mml-inline117-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>) are summarized in <xref ref-type="table" rid="table5-1076998612461832">Table 5</xref>.</p>
<table-wrap id="table5-1076998612461832" position="float">
<label>Table 5</label>
<caption>
<p>Simulation Results as a Function of Survival Pattern (Covariate Prevalence 50<inline-formula id="inline-formula118-1076998612461832">
<mml:math id="mml-inline118-1076998612461832">
<mml:mrow>
<mml:mi mathvariant="italic">%</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula119-1076998612461832">
<mml:math id="mml-inline119-1076998612461832">
<mml:mrow>
<mml:mi mathvariant="normal">N</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">200</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>, No Attrition, and <inline-formula id="inline-formula120-1076998612461832">
<mml:math id="mml-inline120-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mo>ω</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>)</p>
</caption>
<graphic alternate-form-of="table5-1076998612461832" xlink:href="10.3102_1076998612461832-table5.tif"/>
<table>
<thead>
<tr>
<th rowspan="4">Treatment Effect  and Adjustment Strategies</th>
<th colspan="18">Covariate Effect</th>
</tr>
<tr>
<th colspan="6">Small (<inline-formula id="inline-formula121-1076998612461832">
<mml:math id="mml-inline121-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">1</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">.5</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Mild (<inline-formula id="inline-formula122-1076998612461832">
<mml:math id="mml-inline122-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Large (<inline-formula id="inline-formula123-1076998612461832">
<mml:math id="mml-inline123-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">4</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
</tr>
<tr>
<th colspan="3">Rejection (<inline-formula id="inline-formula124-1076998612461832">
<mml:math id="mml-inline124-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>)</th>
<th colspan="3">RSS (<inline-formula id="inline-formula125-1076998612461832">
<mml:math id="mml-inline125-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>)</th>
<th colspan="3">Rejection (<inline-formula id="inline-formula126-1076998612461832">
<mml:math id="mml-inline126-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>)</th>
<th colspan="3">RSS (<inline-formula id="inline-formula127-1076998612461832">
<mml:math id="mml-inline127-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>)</th>
<th colspan="3">Rejection (<inline-formula id="inline-formula128-1076998612461832">
<mml:math id="mml-inline128-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>)</th>
<th colspan="3">RSS (<inline-formula id="inline-formula129-1076998612461832">
<mml:math id="mml-inline129-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>)</th>
</tr>
<tr>
<th>
<inline-formula id="inline-formula130-1076998612461832">
<mml:math id="mml-inline130-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula131-1076998612461832">
<mml:math id="mml-inline131-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula132-1076998612461832">
<mml:math id="mml-inline132-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula133-1076998612461832">
<mml:math id="mml-inline133-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula134-1076998612461832">
<mml:math id="mml-inline134-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula135-1076998612461832">
<mml:math id="mml-inline135-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula136-1076998612461832">
<mml:math id="mml-inline136-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula137-1076998612461832">
<mml:math id="mml-inline137-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula138-1076998612461832">
<mml:math id="mml-inline138-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula139-1076998612461832">
<mml:math id="mml-inline139-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula140-1076998612461832">
<mml:math id="mml-inline140-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula141-1076998612461832">
<mml:math id="mml-inline141-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula142-1076998612461832">
<mml:math id="mml-inline142-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula143-1076998612461832">
<mml:math id="mml-inline143-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula144-1076998612461832">
<mml:math id="mml-inline144-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula145-1076998612461832">
<mml:math id="mml-inline145-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula146-1076998612461832">
<mml:math id="mml-inline146-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula147-1076998612461832">
<mml:math id="mml-inline147-1076998612461832">
<mml:mi mathvariant="italic">τ</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>No (<inline-formula id="inline-formula148-1076998612461832">
<mml:math id="mml-inline148-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>5.1</td>
<td>5.2</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.2</td>
<td>5.1</td>
<td>5.0</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.2</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>5.2</td>
<td>5.3</td>
<td>5.2</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.2</td>
<td>5.0</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.1</td>
<td>5.2</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Small (<inline-formula id="inline-formula149-1076998612461832">
<mml:math id="mml-inline149-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>39</td>
<td>57</td>
<td>54</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>35</td>
<td>52</td>
<td>51</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>28</td>
<td>41</td>
<td>43</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>39</td>
<td>
<bold>58</bold>
</td>
<td>54</td>
<td>1.9</td>
<td>
<bold>2.7</bold>
</td>
<td>2.3</td>
<td>36</td>
<td>
<bold>56</bold>
</td>
<td>54</td>
<td>4.9</td>
<td>
<bold>7.6</bold>
</td>
<td>7.2</td>
<td>32</td>
<td>50</td>
<td>
<bold>52</bold>
</td>
<td>13.1</td>
<td>21.0</td>
<td>
<bold>21.9</bold>
</td>
</tr>
<tr>
<td>Mild (<inline-formula id="inline-formula150-1076998612461832">
<mml:math id="mml-inline150-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.7</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>58</td>
<td>79</td>
<td>76</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>53</td>
<td>74</td>
<td>73</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>42</td>
<td>61</td>
<td>64</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>58</td>
<td>
<bold>80</bold>
</td>
<td>77</td>
<td>1.8</td>
<td>
<bold>2.8</bold>
</td>
<td>2.2</td>
<td>55</td>
<td>
<bold>77</bold>
</td>
<td>76</td>
<td>5.3</td>
<td>
<bold>7.0</bold>
</td>
<td>6.7</td>
<td>47</td>
<td>71</td>
<td>
<bold>74</bold>
</td>
<td>13.0</td>
<td>19.6</td>
<td>
<bold>21.6</bold>
</td>
</tr>
<tr>
<td>Large (<inline-formula id="inline-formula151-1076998612461832">
<mml:math id="mml-inline151-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.9</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>73</td>
<td>91</td>
<td>90</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>68</td>
<td>88</td>
<td>88</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>56</td>
<td>77</td>
<td>80</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>74</td>
<td>
<bold>91</bold>
</td>
<td>90</td>
<td>1.7</td>
<td>
<bold>2.7</bold>
</td>
<td>2.7</td>
<td>70</td>
<td>
<bold>91</bold>
</td>
<td>90</td>
<td>4.8</td>
<td>
<bold>7.0</bold>
</td>
<td>6.5</td>
<td>62</td>
<td>85</td>
<td>
<bold>89</bold>
</td>
<td>12.2</td>
<td>18.8</td>
<td>
<bold>21.2</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1076998612461832">
<p>
<italic>Note:</italic> Rejection is either the Type I error rate when <inline-formula id="inline-formula152-1076998612461832">
<mml:math id="mml-inline152-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> or the power for <inline-formula id="inline-formula153-1076998612461832">
<mml:math id="mml-inline153-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>. For each combination of <inline-formula id="inline-formula154-1076998612461832">
<mml:math id="mml-inline154-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula155-1076998612461832">
<mml:math id="mml-inline155-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, the survival pattern with the highest reduction in sample size and power is presented in boldface.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Almost all the Type I error rates are close to the nominal level across all the strategies when different hazard probability functions are used. There is a curvilinear relation between the power (and thus the reduction in sample size) and the survival pattern if the covariate effect is small: The lowest power and reduction are achieved with <inline-formula id="inline-formula156-1076998612461832">
<mml:math id="mml-inline156-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> and the most adequate power and potential reduction are achieved when τ is set at 1 instead of 3. The results indicate that the distinction between the power levels for <inline-formula id="inline-formula157-1076998612461832">
<mml:math id="mml-inline157-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula158-1076998612461832">
<mml:math id="mml-inline158-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula> decreases while the covariate effect increases to a mild effect. For a large covariate effect, the relation appears to be fairly linear and a much higher power and reduction is achieved when τ increases from <inline-formula id="inline-formula159-1076998612461832">
<mml:math id="mml-inline159-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> to 3, that is, the largest power and reduction are indicated by <inline-formula id="inline-formula160-1076998612461832">
<mml:math id="mml-inline160-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>.</p>
</sec>
<sec id="section12-1076998612461832">
<title>4.4. The Effect of the Attrition Rate</title>
<p>To address the issue of whether strategy performances differ when different attrition rates are used, the results corresponding to various attrition rates (<inline-formula id="inline-formula161-1076998612461832">
<mml:math id="mml-inline161-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula162-1076998612461832">
<mml:math id="mml-inline162-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>, and <inline-formula id="inline-formula163-1076998612461832">
<mml:math id="mml-inline163-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>) are shown in <xref ref-type="table" rid="table6-1076998612461832">Table 6</xref>. The results with a low attrition rate (<inline-formula id="inline-formula164-1076998612461832">
<mml:math id="mml-inline164-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.05</mml:mn>
</mml:math>
</inline-formula>) differ only negligibly from those with no attrition (<inline-formula id="inline-formula165-1076998612461832">
<mml:math id="mml-inline165-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>) and are not shown in the table. For high levels of attrition (<inline-formula id="inline-formula166-1076998612461832">
<mml:math id="mml-inline166-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>), no subjects are found in the last time period for some of the generated data sets, so no parameter estimates are given for these data sets. Since there are so few of these data sets (in this study, at most 34 of 10,000 data sets), they are not included in the simulated data sets.</p>
<table-wrap id="table6-1076998612461832" position="float">
<label>Table 6</label>
<caption>
<p>Simulation Results as a Function of Attrition Rate (Covariate Prevalence 50%, <inline-formula id="inline-formula167-1076998612461832">
<mml:math id="mml-inline167-1076998612461832">
<mml:mrow>
<mml:mi mathvariant="normal">N</mml:mi>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>200</mml:mn>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula168-1076998612461832">
<mml:math id="mml-inline168-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mo>τ</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn mathvariant="italic">1</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn mathvariant="italic">3</mml:mn>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>, and <inline-formula id="inline-formula169-1076998612461832">
<mml:math id="mml-inline169-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mo>ω</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">0.8</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>)</p>
</caption>
<graphic alternate-form-of="table6-1076998612461832" xlink:href="10.3102_1076998612461832-table6.tif"/>
<table>
<thead>
<tr>
<th rowspan="4">Treatment Effect and Adjustment Strategies</th>
<th colspan="18">Covariate Effect</th>
</tr>
<tr>
<th colspan="6">Small (<inline-formula id="inline-formula170-1076998612461832">
<mml:math id="mml-inline170-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">1</mml:mn>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">.5</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Mild (<inline-formula id="inline-formula171-1076998612461832">
<mml:math id="mml-inline171-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
<th colspan="6">Large (<inline-formula id="inline-formula172-1076998612461832">
<mml:math id="mml-inline172-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mn mathvariant="normal">2</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">)</mml:mo>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
<mml:mn mathvariant="normal">4</mml:mn>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>)</th>
</tr>
<tr>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
<th colspan="3">Rejection (%)</th>
<th colspan="3">RSS (%)</th>
</tr>
<tr>
<th>
<inline-formula id="inline-formula173-1076998612461832">
<mml:math id="mml-inline173-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula174-1076998612461832">
<mml:math id="mml-inline174-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula175-1076998612461832">
<mml:math id="mml-inline175-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula176-1076998612461832">
<mml:math id="mml-inline176-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula177-1076998612461832">
<mml:math id="mml-inline177-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula178-1076998612461832">
<mml:math id="mml-inline178-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula179-1076998612461832">
<mml:math id="mml-inline179-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula180-1076998612461832">
<mml:math id="mml-inline180-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula181-1076998612461832">
<mml:math id="mml-inline181-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula182-1076998612461832">
<mml:math id="mml-inline182-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula183-1076998612461832">
<mml:math id="mml-inline183-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula184-1076998612461832">
<mml:math id="mml-inline184-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula185-1076998612461832">
<mml:math id="mml-inline185-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula186-1076998612461832">
<mml:math id="mml-inline186-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula187-1076998612461832">
<mml:math id="mml-inline187-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula188-1076998612461832">
<mml:math id="mml-inline188-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula189-1076998612461832">
<mml:math id="mml-inline189-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>
</th>
<th>
<inline-formula id="inline-formula190-1076998612461832">
<mml:math id="mml-inline190-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>No (<inline-formula id="inline-formula191-1076998612461832">
<mml:math id="mml-inline191-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>)</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>5.1</td>
<td>5.2</td>
<td>5.2</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.2</td>
<td>5.1</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.1</td>
<td>5.2</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>5.2</td>
<td>5.2</td>
<td>5.3</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.2</td>
<td>5.1</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>5.3</td>
<td>5.1</td>
<td>5.2</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Small (<inline-formula id="inline-formula192-1076998612461832">
<mml:math id="mml-inline192-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.5</mml:mn>
</mml:math>
</inline-formula>)</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>39</td>
<td>37</td>
<td>33</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>35</td>
<td>33</td>
<td>31</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>28</td>
<td>26</td>
<td>24</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>
<bold>39</bold>
</td>
<td>38</td>
<td>34</td>
<td>
<bold>1.9</bold>
</td>
<td>1.8</td>
<td>1.4</td>
<td>
<bold>36</bold>
</td>
<td>35</td>
<td>32</td>
<td>
<bold>4.9</bold>
</td>
<td>4.2</td>
<td>3.9</td>
<td>
<bold>32</bold>
</td>
<td>30</td>
<td>27</td>
<td>
<bold>13.1</bold>
</td>
<td>12.5</td>
<td>10.5</td>
</tr>
<tr>
<td>Mild (<inline-formula id="inline-formula193-1076998612461832">
<mml:math id="mml-inline193-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.7</mml:mn>
</mml:math>
</inline-formula>)</td>
</tr>
<tr>
<td> Unadjusted</td>
<td>58</td>
<td>54</td>
<td>51</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>53</td>
<td>50</td>
<td>46</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>42</td>
<td>40</td>
<td>37</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td> Prespecified</td>
<td>
<bold>58</bold>
</td>
<td>55</td>
<td>51</td>
<td>
<bold>1.8</bold>
</td>
<td>1.8</td>
<td>1.3</td>
<td>
<bold>55</bold>
</td>
<td>52</td>
<td>48</td>
<td>
<bold>5.3</bold>
</td>
<td>4.2</td>
<td>3.6</td>
<td>
<bold>47</bold>
</td>
<td>45</td>
<td>41</td>
<td>
<bold>13.0</bold>
</td>
<td>11.8</td>
<td>10.4</td>
</tr>
<tr>
<td>Large (<inline-formula id="inline-formula194-1076998612461832">
<mml:math id="mml-inline194-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.9</mml:mn>
</mml:math>
</inline-formula>)</td>
</tr>
<tr>
<td>Unadjusted</td>
<td>73</td>
<td>70</td>
<td>65</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>68</td>
<td>64</td>
<td>61</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>56</td>
<td>53</td>
<td>49</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>Prespecified</td>
<td>
<bold>74</bold>
</td>
<td>70</td>
<td>66</td>
<td>
<bold>1.7</bold>
</td>
<td>1.6</td>
<td>1.3</td>
<td>
<bold>70</bold>
</td>
<td>66</td>
<td>63</td>
<td>
<bold>4.8</bold>
</td>
<td>4.4</td>
<td>3.7</td>
<td>
<bold>62</bold>
</td>
<td>58</td>
<td>53</td>
<td>
<bold>12.2</bold>
</td>
<td>11.3</td>
<td>9.5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1076998612461832">
<p>
<italic>Note:</italic> Rejection is either the Type I error rate when <inline-formula id="inline-formula195-1076998612461832">
<mml:math id="mml-inline195-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> or the power for <inline-formula id="inline-formula196-1076998612461832">
<mml:math id="mml-inline196-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>R</mml:mi>
<mml:mo stretchy="false">(</mml:mo>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>. For each combination of <inline-formula id="inline-formula197-1076998612461832">
<mml:math id="mml-inline197-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula198-1076998612461832">
<mml:math id="mml-inline198-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, the attrition rate with the highest reduction in sample size and power is presented in boldface.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>No sizable differences between Type I errors with all the strategies or for any covariate effect are observed when different attrition rates are used. Compared with no attrition, the power is slightly reduced with all the strategies with a mild attrition rate (<inline-formula id="inline-formula199-1076998612461832">
<mml:math id="mml-inline199-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.10</mml:mn>
</mml:math>
</inline-formula>), and moderately reduced with <inline-formula id="inline-formula200-1076998612461832">
<mml:math id="mml-inline200-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.25</mml:mn>
</mml:math>
</inline-formula>. With the same comparison, in general the RSS is slightly reduced when the attrition rate increases. In other words, the higher the attrition rate, the smaller the reduction in sample size.</p>
<p>Finally, the same strategy performance differences and similarities are found for each combination of the levels of <inline-formula id="inline-formula201-1076998612461832">
<mml:math id="mml-inline201-1076998612461832">
<mml:mi>p</mml:mi>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula202-1076998612461832">
<mml:math id="mml-inline202-1076998612461832">
<mml:mi>N</mml:mi>
</mml:math>
</inline-formula>, τ, <inline-formula id="inline-formula203-1076998612461832">
<mml:math id="mml-inline203-1076998612461832">
<mml:mi>r</mml:mi>
</mml:math>
</inline-formula>, β<sub>1</sub>, and β<sub>2</sub>. However, the increase in power with the significant-imbalance strategy is slightly higher if τ increases from <inline-formula id="inline-formula204-1076998612461832">
<mml:math id="mml-inline204-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> to 3. We observe similar results for the effect of the design factors in all the other simulation conditions. Despite the commonalities of the results, the effect of the survival pattern on the power is curvy in all the covariate effects for a smaller covariate prevalence of 10%. Moreover, in this case, the reduction in sample size for some combinations of the treatment and covariate effects does not decrease when the attrition rate increases.</p>
</sec>
</sec>
<sec id="section13-1076998612461832">
<title>5. When Is It Worth Measuring a Covariate?</title>
<p>We now return to the question of whether it is more cost-efficient to increase the power using a covariate than by increasing the sample size. To answer the question, we consider RCTs with two treatment groups of equal size and without attrition. We assume that the duration of the study consists of <italic>P</italic> time periods. Following <xref ref-type="bibr" rid="bibr13-1076998612461832">Jóźwiak and Moerbeek (2012)</xref>, two cost functions are defined for the trial. The first function assumes that all the subjects are tracked until the end of the trial even if they experience the event in a previous period. The second function assumes that the subjects are not followed after the event occurs. In this study, we only focus on the first function and assume that the treatment is implemented only at the beginning of the study so that the treatment costs do not depend on the number of time periods the subject remains in the study.</p>
<p>The cost function for an unadjusted design with the covariate not added to the model can be defined as:<disp-formula id="disp-formula10-1076998612461832">
<mml:math id="mml-disp10-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mfenced close=")" open="(">
<mml:mrow>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>e</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>c</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfenced>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula10-1076998612461832" xlink:href="10.3102_1076998612461832-eq10.tif"/>
</disp-formula>
</p>
<p>
<inline-formula id="inline-formula205-1076998612461832">
<mml:math id="mml-inline205-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> are the total costs and <inline-formula id="inline-formula206-1076998612461832">
<mml:math id="mml-inline206-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula> the costs of sampling and recruiting one subject. <inline-formula id="inline-formula207-1076998612461832">
<mml:math id="mml-inline207-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>e</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula208-1076998612461832">
<mml:math id="mml-inline208-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>c</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> are the implementation costs for each subject in the experimental and control group respectively. <inline-formula id="inline-formula209-1076998612461832">
<mml:math id="mml-inline209-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> are the costs of taking one measurement at the end of each time period for each subject. <italic>P</italic> is the number of time periods and <inline-formula id="inline-formula210-1076998612461832">
<mml:math id="mml-inline210-1076998612461832">
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> represents the total unadjusted sample size needed to achieve the desired power <inline-formula id="inline-formula211-1076998612461832">
<mml:math id="mml-inline211-1076998612461832">
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula>. We set the whole expression in brackets in the left side as <inline-formula id="inline-formula212-1076998612461832">
<mml:math id="mml-inline212-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> and these are the costs of sampling, recruiting, and implementing each intervention for a new subject and are to be called the costs at the subject level. <inline-formula id="inline-formula213-1076998612461832">
<mml:math id="mml-inline213-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> are the total costs for each subject in the unadjusted design. The cost function for an adjusted design, which includes a covariate in the model, can be expressed by <inline-formula id="inline-formula214-1076998612461832">
<mml:math id="mml-inline214-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>. <inline-formula id="inline-formula215-1076998612461832">
<mml:math id="mml-inline215-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:math>
</inline-formula> are the additional costs for each subject for measuring the covariate, as is done once at the beginning of the study. <inline-formula id="inline-formula216-1076998612461832">
<mml:math id="mml-inline216-1076998612461832">
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> is the adjusted required number of subjects to achieve the same power.</p>
<p>It is worth measuring a covariate if the following inequality is observed:<disp-formula id="disp-formula11-1076998612461832">
<mml:math id="mml-disp11-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
<mml:mo stretchy="false">⇒</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula11-1076998612461832" xlink:href="10.3102_1076998612461832-eq11.tif"/>
</disp-formula>
</p>
<p>This means the total costs of a trial without a covariate at the power of <inline-formula id="inline-formula217-1076998612461832">
<mml:math id="mml-inline217-1076998612461832">
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:math>
</inline-formula> are larger than the total costs of a trial with a covariate at the same level of power. The RSS is defined above as the reduction in sample size of an adjusted design to give the same power as an unadjusted design. In addition, the RSS on the basis of the unadjusted and adjusted sample sizes can be written as:</p>
<p>
<disp-formula id="disp-formula12-1076998612461832">
<mml:math id="mml-disp12-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">R</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
<mml:mi mathvariant="normal">S</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
<mml:mo stretchy="false">−</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>.</mml:mo>
</mml:math>
<graphic alternate-form-of="disp-formula12-1076998612461832" xlink:href="10.3102_1076998612461832-eq12.tif"/>
</disp-formula>
</p>
<p>So measuring the covariate is cost-efficient if</p>
<p>
<disp-formula id="disp-formula13-1076998612461832">
<label>2</label>
<mml:math id="mml-disp13-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>S</mml:mi>
<mml:mi>S</mml:mi>
<mml:mo stretchy="false">)</mml:mo>
<mml:mo stretchy="false">[</mml:mo>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">+</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">]</mml:mo>
<mml:mo stretchy="false">&lt;</mml:mo>
<mml:mn>1.</mml:mn>
</mml:math>
<graphic alternate-form-of="disp-formula13-1076998612461832" xlink:href="10.3102_1076998612461832-eq13.tif"/>
</disp-formula>
</p>
<p>Using a covariate is thus preferable if the additional costs for measuring the covariate are low relative to <inline-formula id="inline-formula218-1076998612461832">
<mml:math id="mml-inline218-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:mi>P</mml:mi>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> or if the RSS is sufficiently high.</p>
<p>The matrix of plots in <xref ref-type="fig" rid="fig2-1076998612461832">Figure 2</xref> shows the cost ratio <inline-formula id="inline-formula219-1076998612461832">
<mml:math id="mml-inline219-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> as a function of the RSS on the horizontal axes, the number of periods in the columns (<italic>P</italic> = 2 and 8), and the costs of obtaining a measurement at the end of each period in the rows, which are defined relative to the costs at the subject level: <inline-formula id="inline-formula220-1076998612461832">
<mml:math id="mml-inline220-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.5</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula221-1076998612461832">
<mml:math id="mml-inline221-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>2</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>. Within each plot, the four lines represent four different values of the costs of measuring a covariate, relative to the costs at the subject level in the unadjusted design: <inline-formula id="inline-formula222-1076998612461832">
<mml:math id="mml-inline222-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.1</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula223-1076998612461832">
<mml:math id="mml-inline223-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.5</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula224-1076998612461832">
<mml:math id="mml-inline224-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> and <inline-formula id="inline-formula225-1076998612461832">
<mml:math id="mml-inline225-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo mathvariant="normal" stretchy="false">=</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>.</p>
<fig id="fig2-1076998612461832" position="float">
<label>Figure 2.</label>
<caption>
<p>Cost ratio <inline-formula id="inline-formula226-1076998612461832">
<mml:math id="mml-inline226-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> as a function of RSS, number of time periods <italic>P</italic>, and the costs <inline-formula id="inline-formula227-1076998612461832">
<mml:math id="mml-inline227-1076998612461832">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">m</mml:mi>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula> to take the measurements for each period. Dashed line corresponds to <inline-formula id="inline-formula228-1076998612461832">
<mml:math id="mml-inline228-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
</mml:mrow>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mn mathvariant="italic">1</mml:mn>
</mml:mrow>
</mml:math>
</inline-formula>.</p>
</caption>
<graphic xlink:href="10.3102_1076998612461832-fig2.tif"/>
</fig>
<p>For each combination of <italic>P</italic> and <inline-formula id="inline-formula229-1076998612461832">
<mml:math id="mml-inline229-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>, the cost ratio is smaller if <inline-formula id="inline-formula230-1076998612461832">
<mml:math id="mml-inline230-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:math>
</inline-formula> is smaller relative to <inline-formula id="inline-formula231-1076998612461832">
<mml:math id="mml-inline231-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> or if the RSS is larger. It is also clear that the cost ratio for a smaller <inline-formula id="inline-formula232-1076998612461832">
<mml:math id="mml-inline232-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
</mml:math>
</inline-formula> intersects the line <inline-formula id="inline-formula233-1076998612461832">
<mml:math id="mml-inline233-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> at smaller values of the RSS. The cost ratio also decreases if <italic>P</italic> increases or <inline-formula id="inline-formula234-1076998612461832">
<mml:math id="mml-inline234-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> becomes much higher than <inline-formula id="inline-formula235-1076998612461832">
<mml:math id="mml-inline235-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>, since the left-hand side of inequality (2) approaches 0 if <italic>P</italic> or <inline-formula id="inline-formula236-1076998612461832">
<mml:math id="mml-inline236-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> goes to infinity. For larger <inline-formula id="inline-formula237-1076998612461832">
<mml:math id="mml-inline237-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> and <italic>P</italic>, the lines of the cost ratios almost overlap and intersect the line <inline-formula id="inline-formula238-1076998612461832">
<mml:math id="mml-inline238-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula> at small values of the RSS. Therefore, using a covariate can be claimed to be worthwhile even if measuring the covariate is rather expensive.</p>
<p>The main conclusion here is that increasing the power to detect a treatment effect by including a covariate in the model is more cost-efficient if the costs of measuring the covariate are small and the reduction in sample size is large. A low-cost covariate (<inline-formula id="inline-formula239-1076998612461832">
<mml:math id="mml-inline239-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.1</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>) almost always results in <inline-formula id="inline-formula240-1076998612461832">
<mml:math id="mml-inline240-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>a</mml:mi>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>u</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo stretchy="false">&lt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>, so measuring the covariate and using fewer subjects to increase the power are recommended. For higher costs, using a covariate may be preferred for more numerous time periods (<italic>P</italic> = 10) or higher measurement costs (<inline-formula id="inline-formula241-1076998612461832">
<mml:math id="mml-inline241-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>4</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>) but would be discouraged for the reverse conditions. For a reduction in sample size larger than 50%, it is always a good idea to use a covariate even if measuring the covariate is twice as expensive as the subject level costs.</p>
</sec>
<sec id="section14-1076998612461832">
<title>6. Applications</title>
<sec id="section15-1076998612461832">
<title>6.1. The Effect of Behavior Couples Therapy on Drinking Behavior</title>
<p>We consider a study used in Masyn’s dissertation (<xref ref-type="bibr" rid="bibr17-1076998612461832">Masyn, 2003</xref>) as an example to illustrate the strategy presented in this article. The main purposes of the study in <xref ref-type="bibr" rid="bibr17-1076998612461832">Masyn (2003)</xref> were to assess the efficacy of behavior couples therapy (BCT) on drinking behavior of alcohol dependent males and also to find the relationship between drinking and domestic violence. In this study, there were three counseling treatment programs: marital treatment (BCT), individual-based treatment, and attention control treatment. The sample size in these conditions were 56, 56, and 58, respectively, and measurements were taken each 2 months for a period of 1 year. Masyn estimated the effect of BCT relative to the other two programs and the sole covariate indicated whether the wife’s education was beyond high school (71 cases) or not (99 cases).</p>
<p>The results in <xref ref-type="table" rid="table4-1076998612461832">table 2.4</xref> in Masyn’s dissertation are chosen as values for the effect of BCT treatment (<inline-formula id="inline-formula242-1076998612461832">
<mml:math id="mml-inline242-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.59</mml:mn>
</mml:math>
</inline-formula>) and wife’s education (<inline-formula id="inline-formula243-1076998612461832">
<mml:math id="mml-inline243-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.62</mml:mn>
</mml:math>
</inline-formula>), and also for the six baseline logit hazards <inline-formula id="inline-formula244-1076998612461832">
<mml:math id="mml-inline244-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">α</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>j</mml:mi>
</mml:msub>
</mml:math>
</inline-formula> <inline-formula id="inline-formula245-1076998612461832">
<mml:math id="mml-inline245-1076998612461832">
<mml:mo stretchy="false">(</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.99</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1.82</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>2.10</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>2.44</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>2.80</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>3.07</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>. We set our simulation factors’ levels to these values and discuss the results. As the original study, we assume that 42% of subjects are with wives with no eduction beyond high school (<italic>p</italic> = .42), 33% of subjects are allocated to BCT, and all of the subjects complete the survey (<inline-formula id="inline-formula246-1076998612461832">
<mml:math id="mml-inline246-1076998612461832">
<mml:mi>r</mml:mi>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.00</mml:mn>
</mml:math>
</inline-formula>). So, this example shows our strategy can also be used for trials with allocation ratios, covariate prevalences, and number of time points that are different from the ones that were used in the previous sections and the survival function does not necessarily have to be Weibull.</p>
<p>A simulation shows the power to detect the effect of the treatment is estimated at 0.50 in a model without the covariate, and estimated at 0.52 if controlling for the effect of the wife’s education level. Since the sample size of 170 is not sufficient and consequently results in an underpowered study, we consider a higher value for the sample size which could obtain sufficient power. If we have a trial with 350 subjects, then this gives us 82% power to detect the same difference in an unadjusted model, and 84% in the adjusted model. This gain in power can also be expressed by the RSS (3.5<inline-formula id="inline-formula247-1076998612461832">
<mml:math id="mml-inline247-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula>). It means that we can decrease the sample size to 338 and detect the effect of the treatment with 82% power. If the effect of the covariate was estimated to be much larger, for instance equal to −1.39, then we would have 71% unadjusted power to detect the same treatment effect and the prespecified strategy would result in 77% power and this would result in an 11.2% reduction in sample size.</p>
<p>We may assume that measuring the covariate is much less expensive than the total costs to recruit couples and implement the programs (<inline-formula id="inline-formula248-1076998612461832">
<mml:math id="mml-inline248-1076998612461832">
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">≪</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">+</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
</mml:math>
</inline-formula>). Thus, to minimize the costs while maximizing the power, taking the covariate into account is worthwhile from a statistical and also from a financial point of view. One might notice that we suppose the study is planned not only to study event occurrence but also to obtain knowledge about returning to drinking alcohol and its consequences such as violence. Therefore, the subjects will remain in the study even if their event is observed, as is the underlying assumption in the cost functions in the previous section.</p>
</sec>
<sec id="section16-1076998612461832">
<title>6.2. The Effect of a Prevention Program on Math Course-Taking History</title>
<p>A study by <xref ref-type="bibr" rid="bibr8-1076998612461832">Graham (1997)</xref> followed 3,790 high school students from 10th grade through the third semester of college and showed many of them drop out from mathematics class. In addition, the dropout rate was higher for girls than it was for boys. There might be a plethora of strategies to prevent future students from terminating math class such as offering tutoring sessions, establishing learning communities, or conducting an enhanced academic curriculum designed to improve student’s math by additional lectures and assignments. We assume a study that assesses the effect of a dropout prevention program on the risk of students’ mathematics career by tracking them at five different points in time.</p>
<p>Before conducting such a study, one needs to compute the required sample size for achieving a desired power. To do so, one needs to specify the model parameters’ values (baseline hazard probabilities) from the literature and a realistic guess of the program effect. It might also be of interest to investigate the effect of a covariate like gender on increasing power. We use the findings of the study by <xref ref-type="bibr" rid="bibr8-1076998612461832">Graham (1997)</xref> as presented in table <xref ref-type="table" rid="table5-1076998612461832">12.5</xref> of <xref ref-type="bibr" rid="bibr21-1076998612461832">Singer and Willett (2003)</xref> as the baseline logit hazard probabilities of boys in the control condition <inline-formula id="inline-formula249-1076998612461832">
<mml:math id="mml-inline249-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">α</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">(</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>2.13</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.94</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>1.45</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.62</mml:mn>
<mml:mo stretchy="false">,</mml:mo>
<mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.77</mml:mn>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> and the gender effect <inline-formula id="inline-formula250-1076998612461832">
<mml:math id="mml-inline250-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.38</mml:mn>
</mml:math>
</inline-formula> for the proportional discrete-time hazard model. Not only is the survival function not a Weibull function but also the logit hazard function zig-zags over time.</p>
<p>The regression coefficient for the intervention program is chosen <inline-formula id="inline-formula251-1076998612461832">
<mml:math id="mml-inline251-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mn>0.36</mml:mn>
</mml:math>
</inline-formula>, which corresponds to a difference of almost 10% between the two treatment conditions in proportion of the students who remain in math course by the end of the study. In other words, by the end of the third semester of college, 22% of the girls who are enrolled in the intervention program will complete their mathematics courses compared to 13% of those who are not. The alternative proportions for the boys are 34% in the intervention condition in comparison to 23<inline-formula id="inline-formula252-1076998612461832">
<mml:math id="mml-inline252-1076998612461832">
<mml:mi mathvariant="normal">%</mml:mi>
</mml:math>
</inline-formula> in the control condition. Assume we sample 600 students and half of them are randomly assigned to the hypothetical intervention program. Since the gender effect is small, we also investigate the use of covariate adjustment for a mild (<inline-formula id="inline-formula253-1076998612461832">
<mml:math id="mml-inline253-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.69</mml:mn>
</mml:math>
</inline-formula>) and a large (<inline-formula id="inline-formula254-1076998612461832">
<mml:math id="mml-inline254-1076998612461832">
<mml:msub>
<mml:mi mathvariant="italic">β</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1.1</mml:mn>
</mml:math>
</inline-formula>) gender effect.</p>
<p>A simulation study indicates that adjustment of the program effect for gender yields a reduction in required sample size of 2.4%, 7.9%, and 17.8%, corresponding to the small, mild, and large <inline-formula id="inline-formula255-1076998612461832">
<mml:math id="mml-inline255-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, respectively. With the largest RSS, the prespecified strategy increases power from 83% of the unadjusted design to 90% of the adjusted design. We conclude that for an RCT of 600 students at a specific level of power, the prespecified strategy requires a sample size 18% smaller to attain the same level of power. Therefore, one needs 493 students to yield 83% power to detect the real effect of the intervention program if the effect is adjusted for an appropriate strong covariate that substantially influences the risk of the dropout. Sample sizes equal to 553 and 586 are needed for a mild and small covariate effect.</p>
</sec>
</sec>
<sec id="section17-1076998612461832">
<title>7. Conclusions and Discussion</title>
<p>The main purpose of this article is to investigate the extent to which using a predictive covariate increases the power of treatment effect detection. Three different covariate adjustment approaches are compared in a simulated discrete-time hazard model. Based on a simulation study, their performances over various design factor combinations are identified. In this study, the power gain achieved using the adjustment strategies is expressed as the potential reduction in sample size that gives the same power as an unadjusted design.</p>
<p>The overall results indicate that for any combination of τ, <inline-formula id="inline-formula256-1076998612461832">
<mml:math id="mml-inline256-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula257-1076998612461832">
<mml:math id="mml-inline257-1076998612461832">
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">β</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula258-1076998612461832">
<mml:math id="mml-inline258-1076998612461832">
<mml:mi>N</mml:mi>
</mml:math>
</inline-formula>, <inline-formula id="inline-formula259-1076998612461832">
<mml:math id="mml-inline259-1076998612461832">
<mml:mi>p</mml:mi>
</mml:math>
</inline-formula>, and <inline-formula id="inline-formula260-1076998612461832">
<mml:math id="mml-inline260-1076998612461832">
<mml:mi>r</mml:mi>
</mml:math>
</inline-formula>, the prespecified strategy tends to increase the unadjusted power of the treatment effect, and this increase is somewhat greater for a larger covariate effect. The significant-predictor strategy increases the unadjusted power only slightly in comparison with the prespecified strategy if the covariate effect is small. For a larger covariate effect, these two strategies generate roughly the same results. The significant-imbalance strategy only slightly changes the unadjusted power. As a result, the potential reductions in sample size are found with the prespecified and significant-predictor strategies if the covariate effect is large, and the significant-imbalance strategy shows much smaller or even negligible reductions. The power depends on the treatment and covariate effect. A greater observed power value is found with a smaller covariate and larger treatment effect. The reduction in sample size mostly depends on the covariate effect and only slightly on the treatment effect. In other words, a larger reduction is observed for a stronger covariate effect and varies negligibly if the treatment effect changes. The power and reduction are observed to depend on the covariate prevalence. For much smaller covariate prevalence, a higher power and smaller reduction are observed. In addition, the power is highly influenced by taking different sample sizes and increases with a larger sample size. However, the reduction barely changes with different sample sizes. In conclusion, the reduction does not depend on the treatment effect and sample size. The power and reduction also depend on the shape of the hazard probability function. The Weibull distribution with a small value of τ (<inline-formula id="inline-formula261-1076998612461832">
<mml:math id="mml-inline261-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula>) results in the lowest observed value of power and the smallest reduction. For designs with a constant risk of event occurrence (<inline-formula id="inline-formula262-1076998612461832">
<mml:math id="mml-inline262-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>), the higher power and reduction are achieved with a small covariate effect. If the Weibull survival with <inline-formula id="inline-formula263-1076998612461832">
<mml:math id="mml-inline263-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula> is applied, more sufficient power and more potential reduction are observed for a stronger covariate effect. Moreover, the attrition rate slightly impacts the power and reduction in sample size; the higher the attrition rate, the lower the power and reduction in sample size.</p>
<p>We have discussed the use of covariate adjustment strategies in RCTs with continuous-time survival endpoints analysed with Cox proportional hazard models (<xref ref-type="bibr" rid="bibr9-1076998612461832">Hernandez et al., 2006</xref>). From our results, the effect of the covariate adjustment also applies to trials with discrete-time survival endpoints, as are common in the social and behavioral sciences. In addition, <xref ref-type="bibr" rid="bibr9-1076998612461832">Hernandez et al. (2006)</xref> only consider a decreasing hazard probability function (<inline-formula id="inline-formula264-1076998612461832">
<mml:math id="mml-inline264-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">&lt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>). In our study, the covariate adjustment strategies are also investigated for the Weibull survival function with the risk of event occurrence either increasing over time (<inline-formula id="inline-formula265-1076998612461832">
<mml:math id="mml-inline265-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">&gt;</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>) or remaining constant (<inline-formula id="inline-formula266-1076998612461832">
<mml:math id="mml-inline266-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>1</mml:mn>
</mml:math>
</inline-formula>).</p>
<p>Our findings support evidence of a substantial gain in power when a strong predictive covariate is included in the model, especially in trials with 50% covariate prevalence, without attrition, and with the probability of an event concentrated toward the end of the study (<inline-formula id="inline-formula267-1076998612461832">
<mml:math id="mml-inline267-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">τ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>3</mml:mn>
</mml:math>
</inline-formula>). However, the covariate does not increase the power if the correlation between the outcome and the covariate is not strong enough. In this case, even a prespecified strategy does not increase power much and only slightly reduces the sample size. We recommend using the prespecified strategy if a strong predictive covariate is known before the trial is conducted. An alternative can be the significant-predictor strategy if researchers do not know a strong predictive covariate in advance. Since the underlying survival function influences the effect of the covariate adjustment strategies, the shape of the survival function needs to be specified in the planning phase of a trial. Researchers can often guess the survival parameters based on some prior information or findings in the literature. For example, the Weibull shape parameter τ might be expected to be larger than 1 or lie between <inline-formula id="inline-formula268-1076998612461832">
<mml:math id="mml-inline268-1076998612461832">
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>3</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:math>
</inline-formula> and 1. In practice, particularly in longitudinal studies, subjects may leave a trial for unforeseen reasons other than experiencing an event. Since the attrition impacts the power and consequently the reduction, researchers should expect a certain attrition rate if they want to design the trials efficiently. This is why we encourage researchers to consider these factors when designing their investigations.</p>
<p>Although using the covariate can increase the power without increasing the sample size, one should always consider the costs of measuring the covariate. If the costs of measuring a covariate are not offset by the reduction in sample size needed to achieve a desired level of power, using the covariate is not advisable. The second aim of the study was to quantify when measuring a covariate is more cost-efficient. In general, a covariate with costs 10 times lower than the costs at the subject level <inline-formula id="inline-formula269-1076998612461832">
<mml:math id="mml-inline269-1076998612461832">
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">c</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">v</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.1</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> is highly recommended for increasing the statistical power. For higher costs, a covariate is preferable if the trial is long and the costs of obtaining one measurement are considerably higher than the costs at the subject level <inline-formula id="inline-formula270-1076998612461832">
<mml:math id="mml-inline270-1076998612461832">
<mml:mo stretchy="false">(</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>m</mml:mi>
</mml:msub>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>4</mml:mn>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>s</mml:mi>
</mml:msub>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula>. In other words, a longer duration and relatively high measurement costs are conditions that warrant a covariate adjustment for increasing the power. A sufficient reduction in sample size, as is achieved using a strong predictive covariate, always produces a condition that including a covariate should probably be considered for. On the whole, if a covariate can be measured at a negligible cost, it is advisable to measure it, regardless of whether one will use it later in the model for increasing power.</p>
<p>This study focuses primarily on assumptions such as the Weibull distribution with scale parameter <inline-formula id="inline-formula271-1076998612461832">
<mml:math id="mml-inline271-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">λ</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">l</mml:mi>
<mml:mi mathvariant="normal">o</mml:mi>
<mml:mi mathvariant="normal">g</mml:mi>
<mml:mo mathvariant="normal" stretchy="false">(</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo stretchy="false">−</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:math>
</inline-formula> equal to 1.61 (<inline-formula id="inline-formula272-1076998612461832">
<mml:math id="mml-inline272-1076998612461832">
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="italic">ω</mml:mi>
</mml:mrow>
</mml:mrow>
<mml:mo stretchy="false">=</mml:mo>
<mml:mn>0.8</mml:mn>
</mml:math>
</inline-formula>), an equal sample size in both treatment conditions at the beginning of the study, and the maximum length of five time periods for all the subjects. The findings are restricted to simulation results with plausible treatment and covariate effects rather than real data. In addition, we only consider covariate prevalences of 10% and 50%; results with a covariate prevalence of 90% are similar to those with a 10% covariate prevalence. We have not addressed the consequences of covariate adjustment strategies with more than one covariate available. Nor have we studied the effect of strategies using a continuous covariate. Future research might modify these assumptions, for instance unequal allocation to the treatment conditions, various numbers of time periods, and different plausible values for ω such as 0.5 and 0.2. Finding an optimal combination of the design factors using optimality criteria to maximize power while minimizing the costs might also be a topic for future research. The results of the cost section can only be taken as evidence of trials with subjects followed until the end of the study, even if they already experienced the event. So the findings do not have any implications as regards trials that study surviving a disease in subjects only observed until death. In such cases, comparing the two alternative cost functions for increasing power is more complicated since the number of measurements depends on the periods during which the subjects remain in the study in each treatment condition.</p>
<p>To our knowledge, this is the first study on increasing power using a predictive covariate for trials with discrete-time survival endpoints. In conclusion, we hope our findings help researchers in the social and behavioral sciences increase power by including a strong predictive covariate while reducing the financial trial costs.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict" id="fn1-1076998612461832">
<label>Declaration of Conflicting Interests</label>
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1076998612461832">
<label>Funding</label>
<p>The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This research was supported by a VIDI grant from the Netherlands Organization for Scientific Research (NWO) number 452-08-004. </p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allison</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>When is it worth measuring a covariate in a randomized clinical trial?</article-title> <source>Journal of Consulting and Clinical Psychology</source>, <volume>63</volume>, <fpage>339</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr2-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allison</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Faith</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paultre</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pi-Sunyer</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Power and money: Designing statistically powerful studies while minimizing financial costs</article-title>. <source>Psychological Methods</source>, <volume>2</volume>, <fpage>20</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr3-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Chow</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2008</year>). <source>Sample size calculations in clinical research</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Chapman &amp; Hall</publisher-name>.</citation>
</ref>
<ref id="bibr4-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Collett</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2003</year>). <source>Modelling survival data in medical research</source> (<edition>2nd ed</edition>.). <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>Chapman &amp; Hall/CRC</publisher-name>.</citation>
</ref>
<ref id="bibr5-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1972</year>). <article-title>Regression models and life-tables</article-title>. <source>Journal of the Royal Statistical Society, Series B</source>, <volume>34</volume>, <fpage>187</fpage>–<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr6-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Elashoff</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2005</year>). <source>nQuery advisor version 7.0 Users Guide</source>. <publisher-loc>Los Angeles, CA</publisher-loc>: <publisher-name>Statistical Solutions</publisher-name>.</citation>
</ref>
<ref id="bibr7-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galbraith</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marschner</surname>
<given-names>I.C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Guidelines for the design of clinical trials with longitudinal outcomes</article-title>. <source>Controlled Clinical Trials</source>, <volume>23</volume>, <fpage>257</fpage>–<lpage>273</lpage>.</citation>
</ref>
<ref id="bibr8-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>1997</year>). <source>The exodus from mathematics: When and why?</source> <comment>(Unpublished doctoral dissertation)</comment>. <publisher-name>Graduate School of Education, Harvard University</publisher-name>, <publisher-loc>Cambridge, MA</publisher-loc>.</citation>
</ref>
<ref id="bibr9-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Eijkemans</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Steyerberg</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Randomized controlled trials with time-to-event outcomes: How much does prespecified covariate adjustment increase power?</article-title> <source>Annals of Epidemiology</source>, <volume>16</volume>, <fpage>41</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr10-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Steyerberg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Habbema</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements</article-title>. <source>Journal of Clinical Epidemiology</source>, <volume>57</volume>, <fpage>454</fpage>–<lpage>460</lpage>.</citation>
</ref>
<ref id="bibr11-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hintze</surname>
<given-names>D. J. L.</given-names>
</name>
</person-group> (<year>2008</year>). <source>Quick start manual. PASS power analysis and sample size system</source>. <publisher-loc>Kaysville, UT</publisher-loc>: <publisher-name>NCSS</publisher-name>.</citation>
</ref>
<ref id="bibr12-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hosmer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lemeshow</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>May</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <source>Applied survival analysis. Regression modeling of time-to-event data</source> <edition>(2nd. ed.)</edition>. <publisher-loc>Hoboken, NJ</publisher-loc>: <publisher-name>John Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr13-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jóźwiak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moerbeek</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Cost-effective designs for trials with discrete-time survival endpoints</article-title>. <source>Computational Statistics and Data Analysis</source>, <volume>56</volume>, <fpage>2086</fpage>–<lpage>2096</lpage>.</citation>
</ref>
<ref id="bibr14-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jóźwiak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Moerbeek</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Power analysis for trails with discrete-time survival endpoints</article-title>. <source>Journal of Educational and Behavioral Statistics</source>, <volume>37</volume>, <fpage>630</fpage>–<lpage>654</lpage>.</citation>
</ref>
<ref id="bibr15-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Julious</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <source>Sample sizes for clinical trials</source>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>Chapman and Hall/CRC Press</publisher-name>.</citation>
</ref>
<ref id="bibr16-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Machin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2006</year>). <source>Survival analysis: A practical approach</source> (<edition>2nd ed</edition>.). <publisher-loc>Chichester, England</publisher-loc>: <publisher-name>Wiley</publisher-name>.</citation>
</ref>
<ref id="bibr17-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Masyn</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2003</year>). <source>Discrete-time survival mixture analysis for single and recurrent events using latent variables</source> <comment>(Unpublished doctoral dissertation)</comment>. <publisher-name>University of California at Los Angeles, CA</publisher-name>.</citation>
</ref>
<ref id="bibr18-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moerbeek</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>in press</year>). <article-title>Sample size issues for cluster randomized trials with discrete-time survival endpoints</article-title>. <source>Methodology</source>.</citation>
</ref>
<ref id="bibr19-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muthén</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Muthén</surname>
<given-names>B. O.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>How to use a Monte Carlo Study to decide on sample size and determine power</article-title>. <source>Structural Equation Modeling</source>, <volume>9</volume>, <fpage>599</fpage>–<lpage>620</lpage>.</citation>
</ref>
<ref id="bibr20-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Willett</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>It’s about time: Using discrete-time survival analysis to study duration and the timing of events</article-title>. <source>Journal of Educational and Behavior Statistics</source>, <volume>18</volume>, <fpage>155</fpage>–<lpage>195</lpage>.</citation>
</ref>
<ref id="bibr21-1076998612461832">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Willett</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2003</year>). <source>Applied longitudinal data analysis. Modeling change and event occurrence</source>. <publisher-loc>Oxford, England</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>.</citation>
</ref>
<ref id="bibr22-1076998612461832">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Perel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Clayton</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>I.</given-names>
</name>
</person-group>, … <collab collab-type="author">CRASH Trial Collaborators</collab>. (<year>2012</year>). <article-title>Covariate adjustment increased power in randomized controlled trials: An example in traumatic brain injury</article-title>. <source>Journal of Clinical Epidemiology</source>, <volume>65</volume>, <fpage>474</fpage>–<lpage>481</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>